[
  {
    "id": "D01709",
    "type": "drug",
    "name_en": "Loxoprofen sodium hydrate (JP18)",
    "name_ja": "ロキソプロフェン",
    "names_alt": [
      "Lorfenamin (TN)",
      "Loxonin (TN)"
    ],
    "search_name": "Loxoprofen",
    "formula": "C15H17O3. 2H2O. Na",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, COX inhibitor",
    "therapeutic_category": "1149",
    "atc_code": "M01AE19",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "胃腸障害",
        "name_en": "Gastrointestinal disorder",
        "frequency": "high"
      },
      {
        "name": "腎機能障害",
        "name_en": "Renal impairment",
        "frequency": "medium"
      },
      {
        "name": "出血傾向",
        "name_en": "Bleeding tendency",
        "frequency": "medium"
      },
      {
        "name": "肝機能障害",
        "name_en": "Hepatic impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "cat_1149",
    "type": "category",
    "name_ja": "分類1149",
    "name_en": "",
    "code": "1149"
  },
  {
    "id": "ae_0",
    "type": "adverse_effect",
    "name_ja": "胃腸障害",
    "name_en": "Gastrointestinal disorder"
  },
  {
    "id": "ae_1",
    "type": "adverse_effect",
    "name_ja": "腎機能障害",
    "name_en": "Renal impairment"
  },
  {
    "id": "ae_2",
    "type": "adverse_effect",
    "name_ja": "出血傾向",
    "name_en": "Bleeding tendency"
  },
  {
    "id": "ae_3",
    "type": "adverse_effect",
    "name_ja": "肝機能障害",
    "name_en": "Hepatic impairment"
  },
  {
    "id": "D00217",
    "type": "drug",
    "name_en": "Acetaminophen (JP18/USP)",
    "name_ja": "アセトアミノフェン",
    "names_alt": [
      "Paracetamol (INN)",
      "Tylenol (TN)"
    ],
    "search_name": "Acetaminophen",
    "formula": "C8H9NO2",
    "efficacy": "Analgesic, Antipyretic",
    "therapeutic_category": "1141",
    "atc_code": "N02BE01",
    "drug_class": [
      "Anti-inflammatory",
      "Anilide derivative, anti-inflammatory"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_1141",
    "type": "category",
    "name_ja": "分類1141",
    "name_en": "",
    "code": "1141"
  },
  {
    "id": "D00126",
    "type": "drug",
    "name_en": "Ibuprofen (JP18/USP/INN)",
    "name_ja": "イブプロフェン",
    "names_alt": [
      "Advil (TN)",
      "Motrin (TN)"
    ],
    "search_name": "Ibuprofen",
    "formula": "C13H18O2",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, COX inhibitor",
    "therapeutic_category": "1149",
    "atc_code": "C01EB16",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "adverse_effects": [
      {
        "name": "胃腸障害",
        "name_en": "Gastrointestinal disorder",
        "frequency": "high"
      },
      {
        "name": "腎機能障害",
        "name_en": "Renal impairment",
        "frequency": "medium"
      },
      {
        "name": "出血傾向",
        "name_en": "Bleeding tendency",
        "frequency": "medium"
      },
      {
        "name": "肝機能障害",
        "name_en": "Hepatic impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "cyp_CYP2C9",
    "type": "cyp",
    "name_en": "CYP2C9",
    "name_ja": "CYP2C9"
  },
  {
    "id": "D00903",
    "type": "drug",
    "name_en": "Diclofenac potassium (USP)",
    "name_ja": "ジクロフェナク",
    "names_alt": [
      "Cambia (TN)",
      "Cataflam (TN)",
      "Zipsor (TN)"
    ],
    "search_name": "Diclofenac",
    "formula": "C14H10Cl2NO2. K",
    "efficacy": "Anti-inflammatory, COX inhibitor",
    "therapeutic_category": "",
    "atc_code": "D11AX18",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, acetic acid derivatives",
      "Anti-inflammatory drug, phenylacetic acid derivative",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "Transporter inhibitor",
      "SLC22A8 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "adverse_effects": [
      {
        "name": "胃腸障害",
        "name_en": "Gastrointestinal disorder",
        "frequency": "high"
      },
      {
        "name": "腎機能障害",
        "name_en": "Renal impairment",
        "frequency": "medium"
      },
      {
        "name": "出血傾向",
        "name_en": "Bleeding tendency",
        "frequency": "medium"
      },
      {
        "name": "肝機能障害",
        "name_en": "Hepatic impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "D00567",
    "type": "drug",
    "name_en": "Celecoxib (JP18/USP/INN)",
    "name_ja": "セレコキシブ",
    "names_alt": [
      "Celebrex (TN)",
      "Onsenal (TN)"
    ],
    "search_name": "Celecoxib",
    "formula": "C17H14F3N3O2S",
    "efficacy": "Analgesic, Anti-inflammatory, COX-2 inhibitor\nDISEASE   Rheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nAnkylosing spondylitis [DS:H01674]",
    "therapeutic_category": "1149",
    "atc_code": "L01XX33",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Selective COX2 inhibitor",
      "Anti-inflammatory drug, coxibs",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "adverse_effects": [
      {
        "name": "胃腸障害",
        "name_en": "Gastrointestinal disorder",
        "frequency": "high"
      },
      {
        "name": "腎機能障害",
        "name_en": "Renal impairment",
        "frequency": "medium"
      },
      {
        "name": "出血傾向",
        "name_en": "Bleeding tendency",
        "frequency": "medium"
      },
      {
        "name": "肝機能障害",
        "name_en": "Hepatic impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "D00109",
    "type": "drug",
    "name_en": "Aspirin (JP18/USP)",
    "name_ja": "アスピリン",
    "names_alt": [
      "Aspalon (JAN)",
      "Acetylsalicylic acid",
      "Easprin (TN)",
      "Durlaza (TN)"
    ],
    "search_name": "Aspirin",
    "formula": "C9H8O4",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, Antirheumatic, Antiplatelet, COX inhibitor\nDISEASE   Myocardial infarction [DS:H01730]\nUnstable angina pectoris [DS:H01632]\nChronic stable angina [DS:H01632]",
    "therapeutic_category": "1143",
    "atc_code": "A01AD05",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, salicylic acid derivatives"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "胃腸障害",
        "name_en": "Gastrointestinal disorder",
        "frequency": "high"
      },
      {
        "name": "腎機能障害",
        "name_en": "Renal impairment",
        "frequency": "medium"
      },
      {
        "name": "出血傾向",
        "name_en": "Bleeding tendency",
        "frequency": "medium"
      },
      {
        "name": "肝機能障害",
        "name_en": "Hepatic impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "cat_1143",
    "type": "category",
    "name_ja": "分類1143",
    "name_en": "",
    "code": "1143"
  },
  {
    "id": "D00141",
    "type": "drug",
    "name_en": "Indomethacin (USP)",
    "name_ja": "インドメタシン",
    "names_alt": [
      "Indometacin (JP18/INN)",
      "Aconip (TN)",
      "Indocin (TN)"
    ],
    "search_name": "Indomethacin",
    "formula": "C19H16ClNO4",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, COX inhibitor\nDISEASE   Rheumatoid arthritis [DS:H00630]\nAnkylosing spondylitis [DS:H01674]\nAcute gouty arthritis [DS:H01532]",
    "therapeutic_category": "1145",
    "atc_code": "C01EB03",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, acetic acid derivatives",
      "Anti-inflammatory drug, indoleacetic acid derivative"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "胃腸障害",
        "name_en": "Gastrointestinal disorder",
        "frequency": "high"
      },
      {
        "name": "腎機能障害",
        "name_en": "Renal impairment",
        "frequency": "medium"
      },
      {
        "name": "出血傾向",
        "name_en": "Bleeding tendency",
        "frequency": "medium"
      },
      {
        "name": "肝機能障害",
        "name_en": "Hepatic impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "cat_1145",
    "type": "category",
    "name_ja": "分類1145",
    "name_en": "",
    "code": "1145"
  },
  {
    "id": "D00118",
    "type": "drug",
    "name_en": "Naproxen (JP18/USP/INN)",
    "name_ja": "ナプロキセン",
    "names_alt": [
      "Naprosyn (TN)"
    ],
    "search_name": "Naproxen",
    "formula": "C14H14O3",
    "efficacy": "Analgesic, Anti-inflammatory, Antipyretic, COX inhibitor\nDISEASE   Rheumatoid arthritis [DS:H00630]\nAnkylosing spondylitis [DS:H01674]\nPolyarticular juvenile idiopathic arthritis [DS:H01672]\nAcute gout [DS:H01532]",
    "therapeutic_category": "1149",
    "atc_code": "G02CC02",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, propionic acid derivative"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "胃腸障害",
        "name_en": "Gastrointestinal disorder",
        "frequency": "high"
      },
      {
        "name": "腎機能障害",
        "name_en": "Renal impairment",
        "frequency": "medium"
      },
      {
        "name": "出血傾向",
        "name_en": "Bleeding tendency",
        "frequency": "medium"
      },
      {
        "name": "肝機能障害",
        "name_en": "Hepatic impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "D00315",
    "type": "drug",
    "name_en": "Etodolac (JP18/USP/INN)",
    "name_ja": "エトドラク",
    "names_alt": [
      "Lodine (TN)"
    ],
    "search_name": "Etodolac",
    "formula": "C17H21NO3",
    "efficacy": "Analgesic, Anti-inflammatory, COX-2 inhibitor",
    "therapeutic_category": "1149",
    "atc_code": "M01AB08",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, acetic acid derivatives",
      "Selective COX2 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "胃腸障害",
        "name_en": "Gastrointestinal disorder",
        "frequency": "high"
      },
      {
        "name": "腎機能障害",
        "name_en": "Renal impairment",
        "frequency": "medium"
      },
      {
        "name": "出血傾向",
        "name_en": "Bleeding tendency",
        "frequency": "medium"
      },
      {
        "name": "肝機能障害",
        "name_en": "Hepatic impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "D00969",
    "type": "drug",
    "name_en": "Meloxicam (JAN/USP/INN)",
    "name_ja": "メロキシカム",
    "names_alt": [
      "Mobic (TN)"
    ],
    "search_name": "Meloxicam",
    "formula": "C14H13N3O4S2",
    "efficacy": "Analgesic, Anti-inflammatory, COX-2 inhibitor",
    "therapeutic_category": "1149",
    "atc_code": "M01AC06",
    "drug_class": [
      "Anti-inflammatory",
      "Nonsteroidal anti-inflammatory drug (NSAID)",
      "Anti-inflammatory drug, oxicams",
      "Selective COX2 inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "胃腸障害",
        "name_en": "Gastrointestinal disorder",
        "frequency": "high"
      },
      {
        "name": "腎機能障害",
        "name_en": "Renal impairment",
        "frequency": "medium"
      },
      {
        "name": "出血傾向",
        "name_en": "Bleeding tendency",
        "frequency": "medium"
      },
      {
        "name": "肝機能障害",
        "name_en": "Hepatic impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "cyp_CYP3A4",
    "type": "cyp",
    "name_en": "CYP3A4",
    "name_ja": "CYP3A4"
  },
  {
    "id": "D00615",
    "type": "drug",
    "name_en": "Amlodipine besylate (USP)",
    "name_ja": "アムロジピン",
    "names_alt": [
      "Amlodipine besilate (JP18)",
      "Norvasc (TN)"
    ],
    "search_name": "Amlodipine",
    "formula": "C20H25ClN2O5. C6H6O3S",
    "efficacy": "Antihypertensive, Vasodilator, Calcium channel blocker\nDISEASE   Hypertension [DS:H01633]\nChronic stable angina [DS:H01632]\nVasospastic angina [DS:H01632]",
    "therapeutic_category": "2171",
    "atc_code": "C08CA01",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_2171",
    "type": "category",
    "name_ja": "分類2171",
    "name_en": "",
    "code": "2171"
  },
  {
    "id": "D00437",
    "type": "drug",
    "name_en": "Nifedipine (JP18/USP/INN)",
    "name_ja": "ニフェジピン",
    "names_alt": [
      "Adalat (TN)",
      "Afeditab CR (TN)",
      "Procardia (TN)"
    ],
    "search_name": "Nifedipine",
    "formula": "C17H18N2O6",
    "efficacy": "Antihypertensive, Vasodilator, Calcium channel blocker\nDISEASE   Hypertension [DS:H01633]\nVasospastic angina [DS:H01632]\nChronic stable angina [DS:H01632]",
    "therapeutic_category": "2171",
    "atc_code": "C08CA05",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antihypertensive",
      "Dihydropyridine calcium channel blocker",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00400",
    "type": "drug",
    "name_en": "Valsartan (JP18/USP/INN)",
    "name_ja": "バルサルタン",
    "names_alt": [
      "Diovan (TN)"
    ],
    "search_name": "Valsartan",
    "formula": "C24H29N5O3",
    "efficacy": "Antihypertensive, Angiotensin II receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "therapeutic_category": "2149",
    "atc_code": "C09CA03",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin II receptor antagonist",
      "Antihypertensive",
      "Angiotensin II receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "Transporter substrate",
      "ABCC2 substrate",
      "SLCO1B1 substrate",
      "SLCO1B3 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_2149",
    "type": "category",
    "name_ja": "分類2149",
    "name_en": "",
    "code": "2149"
  },
  {
    "id": "D00522",
    "type": "drug",
    "name_en": "Candesartan (USAN/INN)",
    "name_ja": "カンデサルタン",
    "names_alt": [],
    "search_name": "Candesartan",
    "formula": "C24H20N6O3",
    "efficacy": "Antihypertensive, Angiotensin II receptor antagonist",
    "therapeutic_category": "",
    "atc_code": "C09CA06",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin II receptor antagonist",
      "Antihypertensive",
      "Angiotensin II receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "adverse_effects": []
  },
  {
    "id": "D01204",
    "type": "drug",
    "name_en": "Olmesartan medoxomil (JP18/USP)",
    "name_ja": "オルメサルタン",
    "names_alt": [
      "Benicar (TN)",
      "Olmetec (TN)"
    ],
    "search_name": "Olmesartan",
    "formula": "C29H30N6O6",
    "efficacy": "Antihypertensive, Angiotensin II receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "therapeutic_category": "2149",
    "atc_code": "C09CA08",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin II receptor antagonist",
      "Antihypertensive",
      "Angiotensin II receptor antagonist",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCC2 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00627",
    "type": "drug",
    "name_en": "Telmisartan (JP18/USP/INN)",
    "name_ja": "テルミサルタン",
    "names_alt": [
      "Micardis (TN)"
    ],
    "search_name": "Telmisartan",
    "formula": "C33H30N4O2",
    "efficacy": "Antihypertensive, Angiotensin II receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "therapeutic_category": "2149",
    "atc_code": "C09CA07",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin II receptor antagonist",
      "Antihypertensive",
      "Angiotensin II receptor antagonist",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00357",
    "type": "drug",
    "name_en": "Losartan potassium (JP18/USP)",
    "name_ja": "ロサルタン",
    "names_alt": [
      "Cozaar (TN)"
    ],
    "search_name": "Losartan",
    "formula": "C22H22ClN6O. K",
    "efficacy": "Antihypertensive, Angiotensin II receptor antagonist\nDISEASE   Hypertension [DS:H01633]\nNephropathy in type 2 diabetic [DS:H01456]",
    "therapeutic_category": "2149",
    "atc_code": "C09CA01",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin II receptor antagonist",
      "Antihypertensive",
      "Angiotensin II receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "adverse_effects": []
  },
  {
    "id": "D08067",
    "type": "drug",
    "name_en": "Azilsartan medoxomil (USAN)",
    "name_ja": "アジルサルタン",
    "names_alt": [],
    "search_name": "Azilsartan",
    "formula": "C30H24N4O8",
    "efficacy": "Antihypertensive, Angiotensin II receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "therapeutic_category": "",
    "atc_code": "C09CA09",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin II receptor antagonist",
      "Antihypertensive",
      "Angiotensin II receptor antagonist"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00621",
    "type": "drug",
    "name_en": "Enalapril maleate (JP18/USP)",
    "name_ja": "エナラプリル",
    "names_alt": [
      "Renivace (TN)",
      "Vasotec (TN)"
    ],
    "search_name": "Enalapril",
    "formula": "C20H28N2O5. C4H4O4",
    "efficacy": "Antihypertensive, Vasodilator, Angiotensin-converting enzyme inhibitor\nDISEASE   Hypertension [DS:H01633]",
    "therapeutic_category": "2144",
    "atc_code": "C09AA02",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin-converting enzyme inhibitor",
      "Antihypertensive",
      "Angiotensin-converting enzyme inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2144",
    "type": "category",
    "name_ja": "分類2144",
    "name_en": "",
    "code": "2144"
  },
  {
    "id": "D00362",
    "type": "drug",
    "name_en": "Lisinopril (USP)",
    "name_ja": "リシノプリル",
    "names_alt": [
      "Lisinopril hydrate (JP18)",
      "Lisinopril dihydrate",
      "Prinivil (TN)",
      "Zestril (TN)"
    ],
    "search_name": "Lisinopril",
    "formula": "C21H31N3O5. 2H2O",
    "efficacy": "Antihypertensive, Angiotensin-converting enzyme inhibitor\nDISEASE   Hypertension [DS:H01633]",
    "therapeutic_category": "2144",
    "atc_code": "C09AA03",
    "drug_class": [
      "Cardiovascular agent",
      "Renin-angiotensin system inhibitor",
      "Angiotensin-converting enzyme inhibitor",
      "Antihypertensive",
      "Angiotensin-converting enzyme inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00235",
    "type": "drug",
    "name_en": "Atenolol (JP18/USP/INN)",
    "name_ja": "アテノロール",
    "names_alt": [
      "Tenormin (TN)"
    ],
    "search_name": "Atenolol",
    "formula": "C14H22N2O3",
    "efficacy": "Antiarrhythmic, Antihypertensive, Vasodilator, beta1-Adrenergic receptor antagonist\nDISEASE   Hypertension [DS:H01633]\nAngina pectoris due to coronary atherosclerosis [DS:H01632]\nAcute Myocardial Infarction [DS:H01730]",
    "therapeutic_category": "2123",
    "atc_code": "C07AB03",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "beta1-Adrenergic receptor antagonist",
      "Antiarrhythmics",
      "Class II antiarrhythmic agent",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "adverse_effects": [
      {
        "name": "徐脈",
        "name_en": "Bradycardia",
        "frequency": "high"
      },
      {
        "name": "低血圧",
        "name_en": "Hypotension",
        "frequency": "medium"
      },
      {
        "name": "気管支痙攣",
        "name_en": "Bronchospasm",
        "frequency": "medium"
      },
      {
        "name": "倦怠感",
        "name_en": "Fatigue",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "cat_2123",
    "type": "category",
    "name_ja": "分類2123",
    "name_en": "",
    "code": "2123"
  },
  {
    "id": "cyp_CYP2D6",
    "type": "cyp",
    "name_en": "CYP2D6",
    "name_ja": "CYP2D6"
  },
  {
    "id": "ae_4",
    "type": "adverse_effect",
    "name_ja": "徐脈",
    "name_en": "Bradycardia"
  },
  {
    "id": "ae_5",
    "type": "adverse_effect",
    "name_ja": "低血圧",
    "name_en": "Hypotension"
  },
  {
    "id": "ae_6",
    "type": "adverse_effect",
    "name_ja": "気管支痙攣",
    "name_en": "Bronchospasm"
  },
  {
    "id": "ae_7",
    "type": "adverse_effect",
    "name_ja": "倦怠感",
    "name_en": "Fatigue"
  },
  {
    "id": "D00634",
    "type": "drug",
    "name_en": "Bisoprolol fumarate (JP18/USP)",
    "name_ja": "ビソプロロール",
    "names_alt": [
      "Zebeta (TN)"
    ],
    "search_name": "Bisoprolol",
    "formula": "(C18H31NO4)2. C4H4O4",
    "efficacy": "Antihypertensive, Vasodilator, beta1-Adrenergic receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "therapeutic_category": "2123",
    "atc_code": "C07AB07",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "beta-Adrenergic receptor antagonist (Beta blocker)",
      "beta1-Adrenergic receptor antagonist",
      "Antiarrhythmics",
      "Class II antiarrhythmic agent",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "徐脈",
        "name_en": "Bradycardia",
        "frequency": "high"
      },
      {
        "name": "低血圧",
        "name_en": "Hypotension",
        "frequency": "medium"
      },
      {
        "name": "気管支痙攣",
        "name_en": "Bronchospasm",
        "frequency": "medium"
      },
      {
        "name": "倦怠感",
        "name_en": "Fatigue",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D00255",
    "type": "drug",
    "name_en": "Carvedilol (JP18/USP/INN)",
    "name_ja": "カルベジロール",
    "names_alt": [
      "Artist (TN)",
      "Coreg (TN)"
    ],
    "search_name": "Carvedilol",
    "formula": "C24H26N2O4",
    "efficacy": "Antihypertensive, alpha1/beta-Adrenergic receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "therapeutic_category": "2149",
    "atc_code": "C07AG02",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha1 and beta-Adrenergic receptor antagonist",
      "Antihypertensive",
      "alpha1 and beta-Adrenergic receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C9 substrate",
      "CYP2D6 substrate",
      "CYP2E1 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP1A2",
      "CYP2C9",
      "CYP2D6",
      "CYP2E1",
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "cyp_CYP1A2",
    "type": "cyp",
    "name_en": "CYP1A2",
    "name_ja": "CYP1A2"
  },
  {
    "id": "cyp_CYP2E1",
    "type": "cyp",
    "name_en": "CYP2E1",
    "name_ja": "CYP2E1"
  },
  {
    "id": "D00608",
    "type": "drug",
    "name_en": "Doxazosin mesylate (USP)",
    "name_ja": "ドキサゾシン",
    "names_alt": [
      "Doxazosin mesilate (JP18)",
      "Cardura (TN)"
    ],
    "search_name": "Doxazosin",
    "formula": "C23H25N5O5. CH4SO3",
    "efficacy": "Antihypertensive, alpha1-Adrenergic receptor antagonist\nDISEASE   Hypertension [DS:H01633]",
    "therapeutic_category": "2149",
    "atc_code": "C02CA04",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist",
      "Peripherally-acting antiadrenergic",
      "Antihypertensive"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00616",
    "type": "drug",
    "name_en": "Diltiazem hydrochloride (JP18/USP)",
    "name_ja": "ジルチアゼム",
    "names_alt": [
      "Cardizem (TN)",
      "Cartia XT (TN)",
      "Dilacor XR (TN)",
      "Dilt-CD (TN)"
    ],
    "search_name": "Diltiazem",
    "formula": "C22H26N2O4S. HCl",
    "efficacy": "Antiarrhythmic, Antihypertensive, Vasodilator (coronary), Calcium channel blocker\nDISEASE   Hypertension [DS:H01633]\nAngina [DS:H01632]",
    "therapeutic_category": "2171",
    "atc_code": "C05AE03",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel L type blocker",
      "Antiarrhythmics",
      "Antihypertensive",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00887",
    "type": "drug",
    "name_en": "Atorvastatin calcium anhydorous",
    "name_ja": "アトルバスタチン",
    "names_alt": [
      "Lipitor (TN)"
    ],
    "search_name": "Atorvastatin",
    "formula": "(C33H34FN2O5)2. Ca",
    "efficacy": "Antihyperlipidemic, HMG-CoA reductase inhibitor",
    "therapeutic_category": "",
    "atc_code": "C10AA05",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "HMG-CoA reductase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate",
      "SLCO1B1 substrate",
      "SLCO1B3 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D01915",
    "type": "drug",
    "name_en": "Rosuvastatin calcium (JP18/USP)",
    "name_ja": "ロスバスタチン",
    "names_alt": [
      "ZD 4522",
      "Crestor (TN)"
    ],
    "search_name": "Rosuvastatin",
    "formula": "(C22H27FN3O6S)2. Ca",
    "efficacy": "Antihyperlipidemic, HMG-CoA reductase inhibitor\nDISEASE   Hypertriglyceridemia [DS:H01637]\nPrimary dysbetalipoproteinemia; type III hyperlipoproteinemia [DS:H01637]\nHomozygous familial hypercholesterolemia [DS:H00155]",
    "therapeutic_category": "2189",
    "atc_code": "C10AA07",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "HMG-CoA reductase inhibitor",
      "Transporter substrate",
      "ABCG2 substrate",
      "SLCO1B1 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2189",
    "type": "category",
    "name_ja": "分類2189",
    "name_en": "",
    "code": "2189"
  },
  {
    "id": "D00893",
    "type": "drug",
    "name_en": "Pravastatin sodium (JP18/USP)",
    "name_ja": "プラバスタチン",
    "names_alt": [
      "CS-514",
      "Pravachol (TN)"
    ],
    "search_name": "Pravastatin",
    "formula": "C23H35O7. Na",
    "efficacy": "Antihyperlipidemic, HMG-CoA reductase inhibitor\nDISEASE   Hyperlipidemia [DS:H01635 H00155]",
    "therapeutic_category": "2189",
    "atc_code": "C10AA03",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "HMG-CoA reductase inhibitor",
      "Transporter substrate",
      "ABCC2 substrate",
      "SLCO1B1 substrate",
      "SLCO2B1 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D01862",
    "type": "drug",
    "name_en": "Pitavastatin calcium (JAN)",
    "name_ja": "ピタバスタチン",
    "names_alt": [
      "NK 104",
      "Livalo (TN)"
    ],
    "search_name": "Pitavastatin",
    "formula": "(C25H23FNO4)2. Ca",
    "efficacy": "Antihyperlipidemic, HMG-CoA reductase inhibitor\nDISEASE   Primary hyperlipidemia [DS:H01635]\nMixed dyslipidemia [DS:H01635]",
    "therapeutic_category": "",
    "atc_code": "C10AA08",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "HMG-CoA reductase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00434",
    "type": "drug",
    "name_en": "Simvastatin (JP18/USP/INN)",
    "name_ja": "シンバスタチン",
    "names_alt": [
      "MK-733",
      "Zocor (TN)"
    ],
    "search_name": "Simvastatin",
    "formula": "C25H38O5",
    "efficacy": "Antihyperlipidemic, HMG-CoA reductase inhibitor\nDISEASE   Hyperlipidemia [DS:H01635]\nHeterozygous familial hypercholesterolemia [DS:H00155]",
    "therapeutic_category": "2189",
    "atc_code": "C10AA01",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "HMG-CoA reductase inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCG2 substrate",
      "SLCO1B1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D01966",
    "type": "drug",
    "name_en": "Ezetimibe (JAN/USP/INN)",
    "name_ja": "エゼチミブ",
    "names_alt": [
      "Zetia (TN)"
    ],
    "search_name": "Ezetimibe",
    "formula": "C24H21F2NO3",
    "efficacy": "Antihyperlipidemic, Cholesterol absorption inhibitor\nDISEASE   Hyperlipidemia [DS:H01635]\nHomozygous familial hypercholesterolemia [DS:H00155]\nHomozygous sitosterolemia [DS:H00152]",
    "therapeutic_category": "2189",
    "atc_code": "C10AX09",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A1 substrate",
      "UGT1A3 substrate",
      "UGT2B15 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D01366",
    "type": "drug",
    "name_en": "Bezafibrate (JP18/USAN/INN)",
    "name_ja": "ベザフィブラート",
    "names_alt": [
      "Bezatol SR (TN)"
    ],
    "search_name": "Bezafibrate",
    "formula": "C19H20ClNO4",
    "efficacy": "Antihyperlipidemic, Triglyceride synthesis inhibitor, Peroxisome proliferator-activated receptor (PPAR) alpha agonist",
    "therapeutic_category": "2183",
    "atc_code": "C10AB02",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "PPAR alpha agonist",
      "Fibrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2183",
    "type": "category",
    "name_ja": "分類2183",
    "name_en": "",
    "code": "2183"
  },
  {
    "id": "D00565",
    "type": "drug",
    "name_en": "Fenofibrate (JP18/USP/INN)",
    "name_ja": "フェノフィブラート",
    "names_alt": [
      "Antara (TN)",
      "Lipantil (TN)",
      "Lipofen (TN)",
      "Tricor (TN)",
      "Triglide (TN)"
    ],
    "search_name": "Fenofibrate",
    "formula": "C20H21ClO4",
    "efficacy": "Antihyperlipidemic, Triglyceride synthesis inhibitor, Peroxisome proliferator-activated receptor (PPAR) alpha agonist\nDISEASE   Primary hypercholesterolemia or mixed dyslipidemia [DS:H01635]\nHypertriglyceridemia [DS:H01637]",
    "therapeutic_category": "2183",
    "atc_code": "C10AB05",
    "drug_class": [
      "Hypolipidemic agent",
      "Hypolipidemic agent",
      "PPAR alpha agonist",
      "Fibrate",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00944",
    "type": "drug",
    "name_en": "Metformin hydrochloride (JP18/USP)",
    "name_ja": "メトホルミン",
    "names_alt": [
      "Glucophage (TN)"
    ],
    "search_name": "Metformin",
    "formula": "C4H11N5. HCl",
    "efficacy": "Antidiabetic, Hypoglycemic, AMP kinase activator\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "therapeutic_category": "3962",
    "atc_code": "A10BA02",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin sensitizer",
      "Biguanide antidiabetic",
      "Hypoglycemic agent",
      "Biguanide antidiabetic"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "乳酸アシドーシス",
        "name_en": "Lactic acidosis",
        "frequency": "rare"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "high"
      },
      {
        "name": "ビタミンB12低下",
        "name_en": "Vitamin B12 deficiency",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "cat_3962",
    "type": "category",
    "name_ja": "分類3962",
    "name_en": "",
    "code": "3962"
  },
  {
    "id": "ae_8",
    "type": "adverse_effect",
    "name_ja": "乳酸アシドーシス",
    "name_en": "Lactic acidosis"
  },
  {
    "id": "ae_9",
    "type": "adverse_effect",
    "name_ja": "消化器症状",
    "name_en": "GI symptoms"
  },
  {
    "id": "ae_10",
    "type": "adverse_effect",
    "name_ja": "ビタミンB12低下",
    "name_en": "Vitamin B12 deficiency"
  },
  {
    "id": "D00593",
    "type": "drug",
    "name_en": "Glimepiride (JP18/USP/INN)",
    "name_ja": "グリメピリド",
    "names_alt": [
      "Amaryl (TN)"
    ],
    "search_name": "Glimepiride",
    "formula": "C24H34N4O5S",
    "efficacy": "Antidiabetic, Hypoglycemic, Sulfonylurea receptor agonist\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "therapeutic_category": "3961",
    "atc_code": "A10BB12",
    "drug_class": [
      "Antidiabetic agent",
      "Sulfonylurea receptor agonist",
      "Sulfonylurea",
      "Hypoglycemic agent",
      "Sulfonylurea",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_3961",
    "type": "category",
    "name_ja": "分類3961",
    "name_en": "",
    "code": "3961"
  },
  {
    "id": "D00336",
    "type": "drug",
    "name_en": "Glyburide (USP)",
    "name_ja": "グリベンクラミド",
    "names_alt": [
      "Glibenclamide (JP18/INN)",
      "Diabeta (TN)",
      "Glynase (TN)",
      "Micronase (TN)"
    ],
    "search_name": "Glibenclamide",
    "formula": "C23H28ClN3O5S",
    "efficacy": "Antidiabetic, Hypoglycemic\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "therapeutic_category": "3961",
    "atc_code": "A10BB01",
    "drug_class": [
      "Antidiabetic agent",
      "Sulfonylurea receptor agonist",
      "Sulfonylurea",
      "Hypoglycemic agent",
      "Sulfonylurea",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00945",
    "type": "drug",
    "name_en": "Pioglitazone hydrochloride (JP18/USP)",
    "name_ja": "ピオグリタゾン",
    "names_alt": [
      "Actos (TN)"
    ],
    "search_name": "Pioglitazone",
    "formula": "C19H20N2O3S. HCl",
    "efficacy": "Antidiabetic, Peroxisome proliferator-activated receptor (PPAR) gamma agonist\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "therapeutic_category": "3969",
    "atc_code": "A10BG03",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin sensitizer",
      "PPAR gamma agonist",
      "Thiazolidinedione type PPAR agonist",
      "Hypoglycemic agent",
      "Thiazolidinedione type PPAR agonist",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_3969",
    "type": "category",
    "name_ja": "分類3969",
    "name_en": "",
    "code": "3969"
  },
  {
    "id": "cyp_CYP2C8",
    "type": "cyp",
    "name_en": "CYP2C8",
    "name_ja": "CYP2C8"
  },
  {
    "id": "D06645",
    "type": "drug",
    "name_en": "Sitagliptin phosphate (USAN)",
    "name_ja": "シタグリプチン",
    "names_alt": [
      "Sitagliptin phosphate hydrate (JP18)",
      "Sitagliptin phosphate monohydrate",
      "Januvia (TN)"
    ],
    "search_name": "Sitagliptin",
    "formula": "C16H15F6N5O. H3PO4. H2O",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "therapeutic_category": "3969",
    "atc_code": "A10BH01",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "低血糖",
        "name_en": "Hypoglycemia",
        "frequency": "medium"
      },
      {
        "name": "腸閉塞",
        "name_en": "Ileus",
        "frequency": "rare"
      },
      {
        "name": "膵炎",
        "name_en": "Pancreatitis",
        "frequency": "rare"
      }
    ]
  },
  {
    "id": "ae_11",
    "type": "adverse_effect",
    "name_ja": "低血糖",
    "name_en": "Hypoglycemia"
  },
  {
    "id": "ae_12",
    "type": "adverse_effect",
    "name_ja": "腸閉塞",
    "name_en": "Ileus"
  },
  {
    "id": "ae_13",
    "type": "adverse_effect",
    "name_ja": "膵炎",
    "name_en": "Pancreatitis"
  },
  {
    "id": "D07080",
    "type": "drug",
    "name_en": "Vildagliptin (JAN/USAN/INN)",
    "name_ja": "ビルダグリプチン",
    "names_alt": [
      "Equa (TN)",
      "Galvus (TN)"
    ],
    "search_name": "Vildagliptin",
    "formula": "C17H25N3O2",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor",
    "therapeutic_category": "3969",
    "atc_code": "A10BH02",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "低血糖",
        "name_en": "Hypoglycemia",
        "frequency": "medium"
      },
      {
        "name": "腸閉塞",
        "name_en": "Ileus",
        "frequency": "rare"
      },
      {
        "name": "膵炎",
        "name_en": "Pancreatitis",
        "frequency": "rare"
      }
    ]
  },
  {
    "id": "D06553",
    "type": "drug",
    "name_en": "Alogliptin benzoate (JAN/USAN)",
    "name_ja": "アログリプチン",
    "names_alt": [
      "Vipidia (TN)",
      "Nesina (TN)"
    ],
    "search_name": "Alogliptin",
    "formula": "C18H21N5O2. C7H6O2",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "therapeutic_category": "3969",
    "atc_code": "A10BH04",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "低血糖",
        "name_en": "Hypoglycemia",
        "frequency": "medium"
      },
      {
        "name": "腸閉塞",
        "name_en": "Ileus",
        "frequency": "rare"
      },
      {
        "name": "膵炎",
        "name_en": "Pancreatitis",
        "frequency": "rare"
      }
    ]
  },
  {
    "id": "D09566",
    "type": "drug",
    "name_en": "Linagliptin (JAN/USAN/INN)",
    "name_ja": "リナグリプチン",
    "names_alt": [
      "Tradjenta (TN)"
    ],
    "search_name": "Linagliptin",
    "formula": "C25H28N8O2",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "therapeutic_category": "3969",
    "atc_code": "A10BH05",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "低血糖",
        "name_en": "Hypoglycemia",
        "frequency": "medium"
      },
      {
        "name": "腸閉塞",
        "name_en": "Ileus",
        "frequency": "rare"
      },
      {
        "name": "膵炎",
        "name_en": "Pancreatitis",
        "frequency": "rare"
      }
    ]
  },
  {
    "id": "D08616",
    "type": "drug",
    "name_en": "Teneligliptin (INN)",
    "name_ja": "テネリグリプチン",
    "names_alt": [],
    "search_name": "Teneligliptin",
    "formula": "C22H30N6OS",
    "efficacy": "Antidiabetic, Dipeptidyl peptidase-4 (DPP-4) inhibitor",
    "therapeutic_category": "",
    "atc_code": "A10BH08",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "DPP-4 inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "FMO substrate",
      "FMO1 substrate",
      "FMO3 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "FMO inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "低血糖",
        "name_en": "Hypoglycemia",
        "frequency": "medium"
      },
      {
        "name": "腸閉塞",
        "name_en": "Ileus",
        "frequency": "rare"
      },
      {
        "name": "膵炎",
        "name_en": "Pancreatitis",
        "frequency": "rare"
      }
    ]
  },
  {
    "id": "D10459",
    "type": "drug",
    "name_en": "Empagliflozin (JAN/USAN/INN)",
    "name_ja": "エンパグリフロジン",
    "names_alt": [
      "Jardiance (TN)"
    ],
    "search_name": "Empagliflozin",
    "formula": "C23H27ClO7",
    "efficacy": "Antidiabetic, SGLT-2 inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "therapeutic_category": "2190",
    "atc_code": "A10BK03",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "SGLT2 inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A3 substrate",
      "UGT1A8 substrate",
      "UGT1A9 substrate",
      "UGT2B7 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "尿路感染症",
        "name_en": "Urinary tract infection",
        "frequency": "high"
      },
      {
        "name": "性器感染症",
        "name_en": "Genital infection",
        "frequency": "high"
      },
      {
        "name": "ケトアシドーシス",
        "name_en": "Ketoacidosis",
        "frequency": "rare"
      },
      {
        "name": "脱水",
        "name_en": "Dehydration",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "cat_2190",
    "type": "category",
    "name_ja": "分類2190",
    "name_en": "",
    "code": "2190"
  },
  {
    "id": "ae_14",
    "type": "adverse_effect",
    "name_ja": "尿路感染症",
    "name_en": "Urinary tract infection"
  },
  {
    "id": "ae_15",
    "type": "adverse_effect",
    "name_ja": "性器感染症",
    "name_en": "Genital infection"
  },
  {
    "id": "ae_16",
    "type": "adverse_effect",
    "name_ja": "ケトアシドーシス",
    "name_en": "Ketoacidosis"
  },
  {
    "id": "ae_17",
    "type": "adverse_effect",
    "name_ja": "脱水",
    "name_en": "Dehydration"
  },
  {
    "id": "D08897",
    "type": "drug",
    "name_en": "Dapagliflozin (JAN/USAN/INN)",
    "name_ja": "ダパグリフロジン",
    "names_alt": [
      "Forxiga (TN)"
    ],
    "search_name": "Dapagliflozin",
    "formula": "C21H25ClO6",
    "efficacy": "Antidiabetic, SGLT-2 inhibitor",
    "therapeutic_category": "3969",
    "atc_code": "A10BK01",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "SGLT2 inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A9 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "尿路感染症",
        "name_en": "Urinary tract infection",
        "frequency": "high"
      },
      {
        "name": "性器感染症",
        "name_en": "Genital infection",
        "frequency": "high"
      },
      {
        "name": "ケトアシドーシス",
        "name_en": "Ketoacidosis",
        "frequency": "rare"
      },
      {
        "name": "脱水",
        "name_en": "Dehydration",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D09592",
    "type": "drug",
    "name_en": "Canagliflozin (USAN/INN)",
    "name_ja": "カナグリフロジン",
    "names_alt": [
      "Canagliflozin hydrate (JAN)",
      "Invokana (TN)"
    ],
    "search_name": "Canagliflozin",
    "formula": "(C24H25FO5S)2. H2O",
    "efficacy": "Antidiabetic, SGLT-2 inhibitor\nDISEASE   Type 2 diabetes mellitus [DS:H00409]",
    "therapeutic_category": "3969",
    "atc_code": "A10BK02",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "SGLT2 inhibitor",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A9 substrate",
      "UGT2B4 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "尿路感染症",
        "name_en": "Urinary tract infection",
        "frequency": "high"
      },
      {
        "name": "性器感染症",
        "name_en": "Genital infection",
        "frequency": "high"
      },
      {
        "name": "ケトアシドーシス",
        "name_en": "Ketoacidosis",
        "frequency": "rare"
      },
      {
        "name": "脱水",
        "name_en": "Dehydration",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D10195",
    "type": "drug",
    "name_en": "Luseogliflozin hydrate (JAN)",
    "name_ja": "ルセオグリフロジン",
    "names_alt": [
      "Lusefi (TN)"
    ],
    "search_name": "Luseogliflozin",
    "formula": "C23H30O6S. xH2O",
    "efficacy": "Antidiabetic, SGLT-2 inhibitor",
    "therapeutic_category": "3969",
    "atc_code": "A10BK07",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "SGLT2 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "尿路感染症",
        "name_en": "Urinary tract infection",
        "frequency": "high"
      },
      {
        "name": "性器感染症",
        "name_en": "Genital infection",
        "frequency": "high"
      },
      {
        "name": "ケトアシドーシス",
        "name_en": "Ketoacidosis",
        "frequency": "rare"
      },
      {
        "name": "脱水",
        "name_en": "Dehydration",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D03250",
    "type": "drug",
    "name_en": "Insulin glargine (USAN/INN)",
    "name_ja": "インスリン グラルギン",
    "names_alt": [
      "Insulin glargine (genetical recombination) (JP18)",
      "Insulin glargine (genetical recombination) [Insulin glargin biosimilar 1] (JAN)",
      "Insulin glargine (genetical recombination) [Insulin glargin biosimilar 2] (JAN)",
      "Insulin glargine-yfgn",
      "Lantus (TN)"
    ],
    "search_name": "Insulin glargine",
    "formula": "C267H404N72O78S6",
    "efficacy": "Antidiabetic, Insulin receptor agonist\nDISEASE   Diabetes mellitus [DS:H00408 H00409]",
    "therapeutic_category": "2492",
    "atc_code": "A10AE04",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Insulin analog, long-acting",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2492",
    "type": "category",
    "name_ja": "分類2492",
    "name_en": "",
    "code": "2492"
  },
  {
    "id": "D04475",
    "type": "drug",
    "name_en": "Insulin aspart (USP/INN)",
    "name_ja": "インスリン アスパルト",
    "names_alt": [
      "Insulin aspart (genetical recombination) (JP18)",
      "Insulin aspart (genetical recombination) [Insulin aspart biosimilar 1] (JAN)",
      "Insulin X 14",
      "Insulin aspart-szjj",
      "nsulin aspart-xjhz",
      "Merilog (TN)",
      "NovoRapid (TN)",
      "Novolog (TN)",
      "Kirsty (TN)"
    ],
    "search_name": "Insulin aspart",
    "formula": "C256H381N65O79S6",
    "efficacy": "Antidiabetic, Insulin receptor agonist\nDISEASE   Diabetes mellitus [DS:H00408 H00409]",
    "therapeutic_category": "2492",
    "atc_code": "A10AB05",
    "drug_class": [
      "Antidiabetic agent",
      "Insulin preparation",
      "Insulin analog, fast-acting",
      "Metabolizing enzyme inducer",
      "CYP1A2 inducer"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D06404",
    "type": "drug",
    "name_en": "Liraglutide (USAN/INN)",
    "name_ja": "リラグルチド",
    "names_alt": [
      "Liraglutide (genetical recombination) (JAN)",
      "Victoza (TN)"
    ],
    "search_name": "Liraglutide",
    "formula": "C172H265N43O51",
    "efficacy": "Antidiabetic, Glucagon-like peptide 1 (GLP-1) receptor agonist\nDISEASE   Type 2 diabetes mellitus [DS:H00409]\nTYPE      Modified peptide",
    "therapeutic_category": "2499",
    "atc_code": "A10BJ02",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "GLP-1 receptor agonist"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2499",
    "type": "category",
    "name_ja": "分類2499",
    "name_en": "",
    "code": "2499"
  },
  {
    "id": "D09889",
    "type": "drug",
    "name_en": "Dulaglutide (USAN/INN)",
    "name_ja": "デュラグルチド",
    "names_alt": [
      "Dulaglutide (genetical recombination) (JAN)",
      "Trulicity (TN)"
    ],
    "search_name": "Dulaglutide",
    "formula": "C2646H4044N704O836S18",
    "efficacy": "Antidiabetic, Glucagon-like peptide 1 (GLP-1) receptor agonist\nDISEASE   Type 2 diabetes mellitus [DS:H00409]\nTYPE      Modified peptide",
    "therapeutic_category": "2499",
    "atc_code": "A10BJ05",
    "drug_class": [
      "Antidiabetic agent",
      "Hypoglycemic agent",
      "GLP-1 receptor agonist"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00455",
    "type": "drug",
    "name_en": "Omeprazole (JP18/USP/INN)",
    "name_ja": "オメプラゾール",
    "names_alt": [
      "Prilosec (TN)"
    ],
    "search_name": "Omeprazole",
    "formula": "C17H19N3O3S",
    "efficacy": "Antisecretory (gastric acid), Anti-ulcerative, Proton pump inhibitor\nDISEASE   Duodenal ulcer [DS:H01634]\nGastric ulcer [DS:H01634]\nGastroesophageal reflux disease [DS:H01602]\nZollinger-Ellison syndrome [DS:H01522]\nMultiple endocrine adenomas [DS:H01102]",
    "therapeutic_category": "2329",
    "atc_code": "A02BC01",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Proton pump inhibitor (PPI)",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "低マグネシウム血症",
        "name_en": "Hypomagnesemia",
        "frequency": "medium"
      },
      {
        "name": "骨折リスク増加",
        "name_en": "Fracture risk",
        "frequency": "low"
      },
      {
        "name": "Clostridioides difficile感染",
        "name_en": "C. difficile infection",
        "frequency": "low"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "cat_2329",
    "type": "category",
    "name_ja": "分類2329",
    "name_en": "",
    "code": "2329"
  },
  {
    "id": "cyp_CYP2C19",
    "type": "cyp",
    "name_en": "CYP2C19",
    "name_ja": "CYP2C19"
  },
  {
    "id": "ae_18",
    "type": "adverse_effect",
    "name_ja": "低マグネシウム血症",
    "name_en": "Hypomagnesemia"
  },
  {
    "id": "ae_19",
    "type": "adverse_effect",
    "name_ja": "骨折リスク増加",
    "name_en": "Fracture risk"
  },
  {
    "id": "ae_20",
    "type": "adverse_effect",
    "name_ja": "Clostridioides difficile感染",
    "name_en": "C. difficile infection"
  },
  {
    "id": "D00355",
    "type": "drug",
    "name_en": "Lansoprazole (JP18/USP/INN)",
    "name_ja": "ランソプラゾール",
    "names_alt": [
      "Prevacid (TN)"
    ],
    "search_name": "Lansoprazole",
    "formula": "C16H14F3N3O2S",
    "efficacy": "Anti-ulcerative, Proton pump inhibitor\nDISEASE   Duodenal ulcer [DS:H01634]\nH. pylori eradication [DS:H00320]\nGastric ulcer [DS:H01634]\nGastroesophageal reflux disease [DS:H01602]\nZollinger-Ellison syndrome [DS:H01522]",
    "therapeutic_category": "2329",
    "atc_code": "A02BC03",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Proton pump inhibitor (PPI)",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C19 inhibitor",
      "Transporter inhibitor",
      "ABCC2 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "低マグネシウム血症",
        "name_en": "Hypomagnesemia",
        "frequency": "medium"
      },
      {
        "name": "骨折リスク増加",
        "name_en": "Fracture risk",
        "frequency": "low"
      },
      {
        "name": "Clostridioides difficile感染",
        "name_en": "C. difficile infection",
        "frequency": "low"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D00724",
    "type": "drug",
    "name_en": "Rabeprazole sodium (JP18/USP)",
    "name_ja": "ラベプラゾール",
    "names_alt": [
      "Aciphex (TN)",
      "Pariet (TN)"
    ],
    "search_name": "Rabeprazole",
    "formula": "C18H20N3O3S. Na",
    "efficacy": "Antisecretory (gastric acid), Anti-ulcerative, Proton pump inhibitor\nDISEASE   Erosive or ulcerative GERD [DS:H01602]\nDuodenal ulcer [DS:H01634]\nHelicobacter pylori eradication [DS:H00320]\nZollinger-Ellison syndrome [DS:H01522]",
    "therapeutic_category": "2329",
    "atc_code": "A02BC04",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Proton pump inhibitor (PPI)",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "低マグネシウム血症",
        "name_en": "Hypomagnesemia",
        "frequency": "medium"
      },
      {
        "name": "骨折リスク増加",
        "name_en": "Fracture risk",
        "frequency": "low"
      },
      {
        "name": "Clostridioides difficile感染",
        "name_en": "C. difficile infection",
        "frequency": "low"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D01984",
    "type": "drug",
    "name_en": "Esomeprazole magnesium (USP)",
    "name_ja": "エソメプラゾール",
    "names_alt": [
      "Esomeprazole magnesium hydrate (JAN)",
      "Esomeprazole magnesium trihydrate",
      "Nexium (TN)"
    ],
    "search_name": "Esomeprazole",
    "formula": "(C17H18N3O3S)2. 3H2O. Mg",
    "efficacy": "Antisecretory (gastric acid), Anti-ulcerative, Proton pump inhibitor\nDISEASE   Gastroesophageal reflux disease [DS:H01602]\nGastric ulcer [DS:H01634]\nH. pylori eradication [DS:H00320]\nZollinger-Ellison syndrome [DS:H01522]",
    "therapeutic_category": "2329",
    "atc_code": "A02BC05",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Proton pump inhibitor (PPI)",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "低マグネシウム血症",
        "name_en": "Hypomagnesemia",
        "frequency": "medium"
      },
      {
        "name": "骨折リスク増加",
        "name_en": "Fracture risk",
        "frequency": "low"
      },
      {
        "name": "Clostridioides difficile感染",
        "name_en": "C. difficile infection",
        "frequency": "low"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D10466",
    "type": "drug",
    "name_en": "Vonoprazan fumarate (JAN/USAN)",
    "name_ja": "ボノプラザン",
    "names_alt": [
      "Takecab (TN)",
      "Voquezna (TN)"
    ],
    "search_name": "Vonoprazan",
    "formula": "C17H16FN3O2S. C4H4O4",
    "efficacy": "Anti-ulcerative, Proton pump inhibitor\nDISEASE   Erosive esophagitis [DS:H01602]\nHelicobacter pylori infection [DS:H00320]",
    "therapeutic_category": "2329",
    "atc_code": "A02BC08",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Proton pump inhibitor (PPI)",
      "Metabolizing enzyme substrate",
      "CYP2B6 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2B6",
      "CYP2D6",
      "CYP2C19",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "低マグネシウム血症",
        "name_en": "Hypomagnesemia",
        "frequency": "medium"
      },
      {
        "name": "骨折リスク増加",
        "name_en": "Fracture risk",
        "frequency": "low"
      },
      {
        "name": "Clostridioides difficile感染",
        "name_en": "C. difficile infection",
        "frequency": "low"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "cyp_CYP2B6",
    "type": "cyp",
    "name_en": "CYP2B6",
    "name_ja": "CYP2B6"
  },
  {
    "id": "D00318",
    "type": "drug",
    "name_en": "Famotidine (JP18/USP/INN)",
    "name_ja": "ファモチジン",
    "names_alt": [
      "Fluxid (TN)",
      "Pepcid (TN)"
    ],
    "search_name": "Famotidine",
    "formula": "C8H15N7O2S3",
    "efficacy": "Anti-ulcerative, H2 receptor antagonist\nDISEASE   Duodenal ulcer [DS:H01634]\nGastric ulcer [DS:H01634]\nGastroesophageal reflux disease [DS:H01602]\nZollinger-Ellison syndrome [DS:H01522]",
    "therapeutic_category": "2325",
    "atc_code": "A02BA03",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Histamine receptor H2 antagonist",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "Transporter substrate",
      "SLC22A2 substrate",
      "SLC22A8 substrate",
      "Transporter inhibitor",
      "SLC22A2 inhibitor",
      "SLC22A3 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2325",
    "type": "category",
    "name_ja": "分類2325",
    "name_en": "",
    "code": "2325"
  },
  {
    "id": "D00422",
    "type": "drug",
    "name_en": "Ranitidine (USAN/INN)",
    "name_ja": "ラニチジン",
    "names_alt": [],
    "search_name": "Ranitidine",
    "formula": "C13H22N4O3S",
    "efficacy": "Anti-ulcerative, H2 receptor antagonist",
    "therapeutic_category": "",
    "atc_code": "A02BA02",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Histamine receptor H2 antagonist",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter substrate",
      "SLC22A2 substrate",
      "Transporter inhibitor",
      "SLC22A2 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D01827",
    "type": "drug",
    "name_en": "Teprenone (JP18/INN)",
    "name_ja": "テプレノン",
    "names_alt": [
      "Selbex (TN)"
    ],
    "search_name": "Teprenone",
    "formula": "C23H38O",
    "efficacy": "Anti-ulcerative, Mucosal protectant",
    "therapeutic_category": "2329",
    "atc_code": "A02BX15",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D01121",
    "type": "drug",
    "name_en": "Rebamipide (JP18/INN)",
    "name_ja": "レバミピド",
    "names_alt": [
      "Mucosta (TN)"
    ],
    "search_name": "Rebamipide",
    "formula": "C19H15ClN2O4",
    "efficacy": "Anti-ulcerative, Mucin production accelerator",
    "therapeutic_category": "1319",
    "atc_code": "A02BX14",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Gastric mucosal protectant",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_1319",
    "type": "category",
    "name_ja": "分類1319",
    "name_en": "",
    "code": "1319"
  },
  {
    "id": "D01994",
    "type": "drug",
    "name_en": "Mosapride citrate hydrate (JP18)",
    "name_ja": "モサプリド",
    "names_alt": [
      "Mosapride citrate dihydrate",
      "Gasmotin (TN)"
    ],
    "search_name": "Mosapride",
    "formula": "C21H25ClFN3O3. C6H8O7. 2H2O",
    "efficacy": "Prokinetic, Serotonin receptor agonist",
    "therapeutic_category": "2399",
    "atc_code": "A03FA09",
    "drug_class": [
      "Gastrointestinal agent",
      "Propulsive",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_2399",
    "type": "category",
    "name_ja": "分類2399",
    "name_en": "",
    "code": "2399"
  },
  {
    "id": "D00726",
    "type": "drug",
    "name_en": "Metoclopramide (JP18/INN)",
    "name_ja": "メトクロプラミド",
    "names_alt": [
      "Elieten (TN)",
      "Terperan (TN)"
    ],
    "search_name": "Metoclopramide",
    "formula": "C14H22ClN3O2",
    "efficacy": "Anti-emetic, Prokinetic, Dopamine D2 receptor antagonist",
    "therapeutic_category": "2399",
    "atc_code": "A03FA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Gastrointestinal agent",
      "Propulsive",
      "5-HT3-receptor antagonist",
      "Antiemetic",
      "Benzamide type antiemetic",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "adverse_effects": []
  },
  {
    "id": "D01745",
    "type": "drug",
    "name_en": "Domperidone (JP18/USAN/INN)",
    "name_ja": "ドンペリドン",
    "names_alt": [
      "Motilium (TN)"
    ],
    "search_name": "Domperidone",
    "formula": "C22H24ClN5O2",
    "efficacy": "Anti-emetic, Prokinetic, Dopamine D2 receptor antagonist",
    "therapeutic_category": "2399",
    "atc_code": "A03FA03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Gastrointestinal agent",
      "Propulsive",
      "Antiemetic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D02171",
    "type": "drug",
    "name_en": "Sennosides (USP)",
    "name_ja": "センノシド",
    "names_alt": [
      "Pursennid (TN)"
    ],
    "search_name": "Sennoside",
    "formula": "C42H38O20",
    "efficacy": "Laxative",
    "therapeutic_category": "2354",
    "atc_code": "A06AB06",
    "drug_class": [
      "Gastrointestinal agent",
      "Laxative"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2354",
    "type": "category",
    "name_ja": "分類2354",
    "name_en": "",
    "code": "2354"
  },
  {
    "id": "D00564",
    "type": "drug",
    "name_en": "Warfarin sodium (USP)",
    "name_ja": "ワルファリン",
    "names_alt": [
      "Coumadin (TN)",
      "Jantoven (TN)"
    ],
    "search_name": "Warfarin",
    "formula": "C19H15O4. Na",
    "efficacy": "Anticoagulant, Vitamin K antagonist",
    "therapeutic_category": "",
    "atc_code": "B01AA03",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Coumarin anticoagulant",
      "Warfarin and analog",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "adverse_effects": [
      {
        "name": "出血",
        "name_en": "Hemorrhage",
        "frequency": "high"
      },
      {
        "name": "貧血",
        "name_en": "Anemia",
        "frequency": "medium"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "ae_21",
    "type": "adverse_effect",
    "name_ja": "出血",
    "name_en": "Hemorrhage"
  },
  {
    "id": "ae_22",
    "type": "adverse_effect",
    "name_ja": "貧血",
    "name_en": "Anemia"
  },
  {
    "id": "D00769",
    "type": "drug",
    "name_en": "Clopidogrel bisulfate (USP)",
    "name_ja": "クロピドグレル",
    "names_alt": [
      "Clopidogrel sulfate (JP18)",
      "Clopidogrel sulfate tablets (JP18)",
      "Clopidogrel hydrogen sulphate",
      "Isocover (TN)",
      "Plavix (TN)"
    ],
    "search_name": "Clopidogrel",
    "formula": "C16H16ClNO2S. H2SO4",
    "efficacy": "Anticoagulant, Platelet aggregation inhibitor, Purinergic receptor P2Y12 antagonist\nDISEASE   Myocardial infarction [DS:H01730]",
    "therapeutic_category": "3399",
    "atc_code": "B01AC04",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Thienopyridine",
      "P2Y12 receptor antagonist",
      "Thienopyridine",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2B6 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C8 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP1A2",
      "CYP2C19",
      "CYP2B6",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "出血",
        "name_en": "Hemorrhage",
        "frequency": "high"
      },
      {
        "name": "貧血",
        "name_en": "Anemia",
        "frequency": "medium"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "cat_3399",
    "type": "category",
    "name_ja": "分類3399",
    "name_en": "",
    "code": "3399"
  },
  {
    "id": "D05597",
    "type": "drug",
    "name_en": "Prasugrel hydrochloride (JAN/USAN)",
    "name_ja": "プラスグレル",
    "names_alt": [
      "Effient (TN)"
    ],
    "search_name": "Prasugrel",
    "formula": "C20H20FNO3S. HCl",
    "efficacy": "Platelet aggregation inhibitor, Purinergic receptor P2Y12 antagonist\nDISEASE   Unstable angina [DS:H01632]\nMyocardial infarction [DS:H01730]",
    "therapeutic_category": "3399",
    "atc_code": "B01AC22",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Thienopyridine",
      "P2Y12 receptor antagonist",
      "Thienopyridine"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D03213",
    "type": "drug",
    "name_en": "Apixaban (JAN/USAN/INN)",
    "name_ja": "アピキサバン",
    "names_alt": [
      "Eliquis (TN)"
    ],
    "search_name": "Apixaban",
    "formula": "C25H25N5O4",
    "efficacy": "Anticoagulant, Antithrombotic, Factor Xa inhibitor\nDISEASE   Deep vein thrombosis [DS:H01723]",
    "therapeutic_category": "3339",
    "atc_code": "B01AF02",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Factor Xa inhibitor",
      "Direct oral anticoagulant (DOAC)",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A5",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "出血",
        "name_en": "Hemorrhage",
        "frequency": "high"
      },
      {
        "name": "貧血",
        "name_en": "Anemia",
        "frequency": "medium"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "cat_3339",
    "type": "category",
    "name_ja": "分類3339",
    "name_en": "",
    "code": "3339"
  },
  {
    "id": "cyp_CYP3A5",
    "type": "cyp",
    "name_en": "CYP3A5",
    "name_ja": "CYP3A5"
  },
  {
    "id": "D07086",
    "type": "drug",
    "name_en": "Rivaroxaban (JAN/USAN/INN)",
    "name_ja": "リバーロキサバン",
    "names_alt": [
      "Xarelto (TN)"
    ],
    "search_name": "Rivaroxaban",
    "formula": "C19H18ClN3O5S",
    "efficacy": "Antithrombotic, Factor Xa inhibitor",
    "therapeutic_category": "3339",
    "atc_code": "B01AF01",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Factor Xa inhibitor",
      "Direct oral anticoagulant (DOAC)",
      "Metabolizing enzyme substrate",
      "CYP2J2 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate",
      "ABCG2 substrate"
    ],
    "cyp_enzymes": [
      "CYP2J2",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "出血",
        "name_en": "Hemorrhage",
        "frequency": "high"
      },
      {
        "name": "貧血",
        "name_en": "Anemia",
        "frequency": "medium"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "cyp_CYP2J2",
    "type": "cyp",
    "name_en": "CYP2J2",
    "name_ja": "CYP2J2"
  },
  {
    "id": "D09546",
    "type": "drug",
    "name_en": "Edoxaban tosilate hydrate (JAN)",
    "name_ja": "エドキサバン",
    "names_alt": [
      "Edoxaban tosylate monohydrate",
      "Lixiana (TN)",
      "Savaysa (TN)"
    ],
    "search_name": "Edoxaban",
    "formula": "C24H30ClN7O4S. C7H8O3S. H2O",
    "efficacy": "Antithrombotic, Factor Xa inhibitor",
    "therapeutic_category": "3339",
    "atc_code": "B01AF03",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Factor Xa inhibitor",
      "Direct oral anticoagulant (DOAC)",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "出血",
        "name_en": "Hemorrhage",
        "frequency": "high"
      },
      {
        "name": "貧血",
        "name_en": "Anemia",
        "frequency": "medium"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D07082",
    "type": "drug",
    "name_en": "Dabigatran etexilate mesylate (USAN)",
    "name_ja": "ダビガトラン",
    "names_alt": [
      "Dabigatran etexilate methanesulfonate (JAN)",
      "Dabigatran etexilate mesilate",
      "Pradaxa (TN)"
    ],
    "search_name": "Dabigatran",
    "formula": "C34H41N7O5. CH4SO3",
    "efficacy": "Anticoagulant, Thrombin inhibitor",
    "therapeutic_category": "3339",
    "atc_code": "B01AE07",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Thrombin inhibitor",
      "Direct oral anticoagulant (DOAC)",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "出血",
        "name_en": "Hemorrhage",
        "frequency": "high"
      },
      {
        "name": "貧血",
        "name_en": "Anemia",
        "frequency": "medium"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D01896",
    "type": "drug",
    "name_en": "Cilostazol (JP18/USP/INN)",
    "name_ja": "シロスタゾール",
    "names_alt": [
      "Pletal (TN)"
    ],
    "search_name": "Cilostazol",
    "formula": "C20H27N5O2",
    "efficacy": "Vasodilator, Platelet aggregation inhibitor, Phosphodiesterase inhibitor",
    "therapeutic_category": "3399",
    "atc_code": "B01AC23",
    "drug_class": [
      "Cardiovascular agent",
      "Phosphodiesterase III inhibitor",
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6",
      "CYP2C19",
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D01028",
    "type": "drug",
    "name_en": "Ticlopidine hydrochloride (JP18/USP)",
    "name_ja": "チクロピジン",
    "names_alt": [
      "Ticlid (TN)"
    ],
    "search_name": "Ticlopidine",
    "formula": "C14H14ClNS. HCl",
    "efficacy": "Anticoagulant, Platelet aggregation inhibitor, Purinergic receptor P2Y12 antagonist\nDISEASE   Thrombotic thrombocytopenic purpura [DS:H00225]\nAplastic anemia [DS:H01132]",
    "therapeutic_category": "3399",
    "atc_code": "B01AC05",
    "drug_class": [
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent",
      "Thienopyridine",
      "P2Y12 receptor antagonist",
      "Thienopyridine",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "CYP2B6 inhibitor",
      "CYP2C19 inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "出血",
        "name_en": "Hemorrhage",
        "frequency": "high"
      },
      {
        "name": "貧血",
        "name_en": "Anemia",
        "frequency": "medium"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D00229",
    "type": "drug",
    "name_en": "Amoxicillin (USP)",
    "name_ja": "アモキシシリン",
    "names_alt": [
      "Amoxicillin hydrate (JP18)",
      "Amoxicilline (INN)",
      "Amoxicillin trihydrate",
      "Amoxil (TN)",
      "Dispermox (TN)",
      "Pasetocin (TN)"
    ],
    "search_name": "Amoxicillin",
    "formula": "C16H19N3O5S. 3H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Gonorrhea [DS:H00315]\nHelicobacter pylori infection [DS:H00320]",
    "therapeutic_category": "6131",
    "atc_code": "J01CA04",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Penicillin",
      "Extended spectrum penicillin"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_6131",
    "type": "category",
    "name_ja": "分類6131",
    "name_en": "",
    "code": "6131"
  },
  {
    "id": "D00204",
    "type": "drug",
    "name_en": "Ampicillin (USP/INN)",
    "name_ja": "アンピシリン",
    "names_alt": [
      "Anhydrous ampicillin (JP18)",
      "Omnipen (TN)"
    ],
    "search_name": "Ampicillin",
    "formula": "C16H19N3O4S",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "therapeutic_category": "",
    "atc_code": "J01CA01",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Penicillin",
      "Extended spectrum penicillin"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D01680",
    "type": "drug",
    "name_en": "Cefcapene pivoxil hydrochloride hydrate (JP18)",
    "name_ja": "セフカペン ピボキシル",
    "names_alt": [
      "S 1108",
      "Flomox (TN)"
    ],
    "search_name": "Cefcapene pivoxil",
    "formula": "C23H29N5O8S2. HCl. H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "therapeutic_category": "6132",
    "atc_code": "J01DD17",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Third-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_6132",
    "type": "category",
    "name_ja": "分類6132",
    "name_en": "",
    "code": "6132"
  },
  {
    "id": "D01628",
    "type": "drug",
    "name_en": "Cefditoren pivoxil (JP18/USAN)",
    "name_ja": "セフジトレン ピボキシル",
    "names_alt": [
      "Meiact (TN)",
      "Spectracef (TN)"
    ],
    "search_name": "Cefditoren pivoxil",
    "formula": "C25H28N6O7S3",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor\nDISEASE   Pharyngitis/tonsillitis [DS:H01424]",
    "therapeutic_category": "6132",
    "atc_code": "J01DD16",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "Third-generation cephalosporin",
      "Oxyimino beta-lactam"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00906",
    "type": "drug",
    "name_en": "Cephalexin (USP)",
    "name_ja": "セファレキシン",
    "names_alt": [
      "Cephalexin monohydrate",
      "Cefalexin",
      "Keftab (TN)",
      "Panixine disperdose (TN)"
    ],
    "search_name": "Cephalexin",
    "formula": "C16H17N3O4S. H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "therapeutic_category": "",
    "atc_code": "J01DB01",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Cephalosporin skeleton group",
      "Cephem",
      "First-generation cephalosporin"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D02134",
    "type": "drug",
    "name_en": "Azithromycin hydrate (JP18)",
    "name_ja": "アジスロマイシン",
    "names_alt": [
      "Azithromycin dihydrate",
      "Zithromac (TN)",
      "Zmax (TN)",
      "Azimycin (TN)"
    ],
    "search_name": "Azithromycin",
    "formula": "C38H72N2O12. 2H2O",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Urethritis due to Chlamydia trachomatis [DS:H00347]\nDisseminated Mycobacterium avium complex (MAC) disease [DS:H01458]",
    "therapeutic_category": "1317",
    "atc_code": "J01FA10",
    "drug_class": [
      "Antibacterial",
      "Macrolide antibiotic",
      "15-Membered ring macrolide antibiotic",
      "Transporter substrate",
      "ABCB1 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "high"
      },
      {
        "name": "QT延長",
        "name_en": "QT prolongation",
        "frequency": "low"
      },
      {
        "name": "肝機能障害",
        "name_en": "Hepatic impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "cat_1317",
    "type": "category",
    "name_ja": "分類1317",
    "name_en": "",
    "code": "1317"
  },
  {
    "id": "ae_23",
    "type": "adverse_effect",
    "name_ja": "QT延長",
    "name_en": "QT prolongation"
  },
  {
    "id": "D00276",
    "type": "drug",
    "name_en": "Clarithromycin (JP18/USP/INN)",
    "name_ja": "クラリスロマイシン",
    "names_alt": [
      "Biaxin (TN)"
    ],
    "search_name": "Clarithromycin",
    "formula": "C38H69NO13",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Pharyngitis/tonsillitis [DS:H01424]\nHelicobacter pylori infection [DS:H00320]",
    "therapeutic_category": "6149",
    "atc_code": "J01FA09",
    "drug_class": [
      "Antibacterial",
      "Macrolide antibiotic",
      "14-membered ring macrolide antibiotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "high"
      },
      {
        "name": "QT延長",
        "name_en": "QT prolongation",
        "frequency": "low"
      },
      {
        "name": "肝機能障害",
        "name_en": "Hepatic impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "cat_6149",
    "type": "category",
    "name_ja": "分類6149",
    "name_en": "",
    "code": "6149"
  },
  {
    "id": "D00140",
    "type": "drug",
    "name_en": "Erythromycin (JP18/USP/INN)",
    "name_ja": "エリスロマイシン",
    "names_alt": [
      "Akne-mycin (TN)",
      "Eryc (TN)",
      "Erygel (TN)",
      "Pce (TN)",
      "Staticin (TN)",
      "T-stat (TN)"
    ],
    "search_name": "Erythromycin",
    "formula": "C37H67NO13",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Acne vulgaris [DS:H01445]\nListeriosis [DS:H00332]\nPertussis [DS:H00319]\nDiphtheria [DS:H00343]\nAmebiasis [DS:H00360]\nSyphilis [DS:H00354]\nLegionnaires' disease [DS:H00311]",
    "therapeutic_category": "6141",
    "atc_code": "D10AF02",
    "drug_class": [
      "Antibacterial",
      "Macrolide antibiotic",
      "14-membered ring macrolide antibiotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "adverse_effects": [
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "high"
      },
      {
        "name": "QT延長",
        "name_en": "QT prolongation",
        "frequency": "low"
      },
      {
        "name": "肝機能障害",
        "name_en": "Hepatic impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "cat_6141",
    "type": "category",
    "name_ja": "分類6141",
    "name_en": "",
    "code": "6141"
  },
  {
    "id": "cyp_CYP3A",
    "type": "cyp",
    "name_en": "CYP3A",
    "name_ja": "CYP3A"
  },
  {
    "id": "D00588",
    "type": "drug",
    "name_en": "Levofloxacin (USP)",
    "name_ja": "レボフロキサシン",
    "names_alt": [
      "Levofloxacin hydrate (JP18)",
      "Levofloxacin hemihydrate",
      "Iquix (TN)",
      "Levaquin (TN)",
      "Quixin (TN)"
    ],
    "search_name": "Levofloxacin",
    "formula": "(C18H20FN3O4)2. H2O",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor\nDISEASE   Inhalational anthrax [DS:H00328]\nPlague [DS:H00297]\nUncomplicated urinary tract infections [DS:H01176]",
    "therapeutic_category": "1319",
    "atc_code": "J01MA12",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone",
      "Antitubercular",
      "Transporter substrate",
      "SLCO1A2 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "腱障害",
        "name_en": "Tendon disorder",
        "frequency": "low"
      },
      {
        "name": "QT延長",
        "name_en": "QT prolongation",
        "frequency": "low"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      },
      {
        "name": "光線過敏症",
        "name_en": "Photosensitivity",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "ae_24",
    "type": "adverse_effect",
    "name_ja": "腱障害",
    "name_en": "Tendon disorder"
  },
  {
    "id": "ae_25",
    "type": "adverse_effect",
    "name_ja": "光線過敏症",
    "name_en": "Photosensitivity"
  },
  {
    "id": "D00186",
    "type": "drug",
    "name_en": "Ciprofloxacin (JP18/USP/INN)",
    "name_ja": "シプロフロキサシン",
    "names_alt": [
      "Cipro (TN)",
      "Otiprio (TN)"
    ],
    "search_name": "Ciprofloxacin",
    "formula": "C17H18FN3O3",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor\nDISEASE   Inhalational anthrax [DS:H00328]\nPlague [DS:H00297]",
    "therapeutic_category": "6241",
    "atc_code": "J01MA02",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "腱障害",
        "name_en": "Tendon disorder",
        "frequency": "low"
      },
      {
        "name": "QT延長",
        "name_en": "QT prolongation",
        "frequency": "low"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      },
      {
        "name": "光線過敏症",
        "name_en": "Photosensitivity",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "cat_6241",
    "type": "category",
    "name_ja": "分類6241",
    "name_en": "",
    "code": "6241"
  },
  {
    "id": "D00874",
    "type": "drug",
    "name_en": "Moxifloxacin hydrochloride (JAN/USP)",
    "name_ja": "モキシフロキサシン",
    "names_alt": [
      "Avelox (TN)",
      "Vigamox (TN)"
    ],
    "search_name": "Moxifloxacin",
    "formula": "C21H24FN3O4. HCl",
    "efficacy": "Antibacterial, Nucleic acid biosynthesis inhibitor\nDISEASE   Plague [DS:H00297]\nBacterial conjunctivitis [DS:H01366]",
    "therapeutic_category": "1319",
    "atc_code": "J01MA14",
    "drug_class": [
      "Antibacterial",
      "Quinolone",
      "Fluoroquinolone"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "腱障害",
        "name_en": "Tendon disorder",
        "frequency": "low"
      },
      {
        "name": "QT延長",
        "name_en": "QT prolongation",
        "frequency": "low"
      },
      {
        "name": "消化器症状",
        "name_en": "GI symptoms",
        "frequency": "medium"
      },
      {
        "name": "光線過敏症",
        "name_en": "Photosensitivity",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D00850",
    "type": "drug",
    "name_en": "Minocycline hydrochloride (JP18/USP)",
    "name_ja": "ミノサイクリン",
    "names_alt": [
      "Arestin (TN)",
      "Dynacin (TN)",
      "Minocin (TN)",
      "Solodyn (TN)"
    ],
    "search_name": "Minocycline",
    "formula": "C23H27N3O7. HCl",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Rocky Mountain spotted fever [DS:H00323]\nTyphus fever [DS:H00322]\nQ fever [DS:H00310]\nLymphogranuloma venereum [DS:H00348]\nPsittacosis [DS:H00350]\nTrachoma [DS:H00349]\nRelapsing fever [DS:H00427]\nChancroid [DS:H00305]\nPlague [DS:H00297]\nTularemia [DS:H00312]\nCholera [DS:H00110]\nCampylobacter fetus infections [DS:H00321]\nBrucellosis [DS:H00325]\nBartonellosis [DS:H00326]\nGranuloma inguinale [DS:H01415]\nSyphilis [DS:H00354]\nYaws [DS:H01318]\nListeriosis [DS:H00332]\nAnthrax [DS:H00328]\nVincent's infection [DS:H01440]\nActinomycosis [DS:H01325]\nAcute intestinal amebiasis [DS:H00360]\nAcne vulgaris [DS:H01445]",
    "therapeutic_category": "2760",
    "atc_code": "A01AB23",
    "drug_class": [
      "Antibacterial",
      "Tetracycline antibiotic"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2760",
    "type": "category",
    "name_ja": "分類2760",
    "name_en": "",
    "code": "2760"
  },
  {
    "id": "D00307",
    "type": "drug",
    "name_en": "Doxycycline (USP)",
    "name_ja": "ドキシサイクリン",
    "names_alt": [
      "Doxycycline hydrate",
      "Monodox (TN)",
      "Oracea (TN)",
      "Vibramycin (TN)"
    ],
    "search_name": "Doxycycline",
    "formula": "C22H24N2O8. H2O",
    "efficacy": "Antibacterial, Protein biosynthesis inhibitor\nDISEASE   Rocky Mountain spotted fever [DS:H00323]\nTyphus fever [DS:H00322]\nQ fever [DS:H00310]\nRickettsialpox [DS:H02379]\nLymphogranuloma venereum [DS:H00348]\nPsittacosis [DS:H00350]\nTrachoma [DS:H00349]\nRelapsing fever [DS:H00427]\nChancroid [DS:H00305]\nPlague [DS:H00297]\nTularemia [DS:H00312]\nCholera [DS:H00110]\nCampylobacter fetus infections [DS:H00321]\nBrucellosis [DS:H00325]\nBartonellosis [DS:H00326]\nGranuloma inguinale [DS:H01415]\nAnthrax [DS:H00328]\nGonorrhea [DS:H00315]\nSyphilis [DS:H00354]\nYaws [DS:H01318]\nListeriosis [DS:H00332]\nVincent's infection [DS:H01440]\nActinomycosis [DS:H01325]\nAmebiasis [DS:H00360]\nSevere acne [DS:H01445]",
    "therapeutic_category": "",
    "atc_code": "A01AB22",
    "drug_class": [
      "Antibacterial",
      "Tetracycline antibiotic"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00447",
    "type": "drug",
    "name_en": "Sulfamethoxazole (JP18/USP/INN)",
    "name_ja": "スルファメトキサゾール",
    "names_alt": [
      "Gantanol (TN)"
    ],
    "search_name": "Sulfamethoxazole",
    "formula": "C10H11N3O3S",
    "efficacy": "Antibacterial, Folic acid biosynthesis inhibitor",
    "therapeutic_category": "",
    "atc_code": "J01EC01",
    "drug_class": [
      "Antibacterial",
      "Sulfonamide antibacterial",
      "Intermediate-acting sulfonamide"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00212",
    "type": "drug",
    "name_en": "Vancomycin (USP)",
    "name_ja": "バンコマイシン",
    "names_alt": [
      "Vancocin (TN)"
    ],
    "search_name": "Vancomycin",
    "formula": "C66H75Cl2N9O24",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "therapeutic_category": "",
    "atc_code": "A07AA09",
    "drug_class": [
      "Antibacterial",
      "Glycopeptide antibiotic"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D02222",
    "type": "drug",
    "name_en": "Meropenem (USP)",
    "name_ja": "メロペネム",
    "names_alt": [
      "Meropenem hydrate (JP18)",
      "Meropenem trihydrate",
      "Merrem (TN)"
    ],
    "search_name": "Meropenem",
    "formula": "C17H25N3O5S. 3H2O",
    "efficacy": "Antibacterial, Cell wall biosynthesis inhibitor",
    "therapeutic_category": "6139",
    "atc_code": "J01DH02",
    "drug_class": [
      "Antibacterial",
      "beta-Lactam antibiotic",
      "Penicillin skeleton group",
      "Carbapenem"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "高カリウム血症",
        "name_en": "Hyperkalemia",
        "frequency": "medium"
      },
      {
        "name": "めまい",
        "name_en": "Dizziness",
        "frequency": "medium"
      },
      {
        "name": "腎機能障害",
        "name_en": "Renal impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "cat_6139",
    "type": "category",
    "name_ja": "分類6139",
    "name_en": "",
    "code": "6139"
  },
  {
    "id": "ae_26",
    "type": "adverse_effect",
    "name_ja": "高カリウム血症",
    "name_en": "Hyperkalemia"
  },
  {
    "id": "ae_27",
    "type": "adverse_effect",
    "name_ja": "めまい",
    "name_en": "Dizziness"
  },
  {
    "id": "D00409",
    "type": "drug",
    "name_en": "Metronidazole (JP18/USP/INN)",
    "name_ja": "メトロニダゾール",
    "names_alt": [
      "Flagyl (TN)",
      "Noritate (TN)",
      "Nuvessa (TN)",
      "Vandazole (TN)"
    ],
    "search_name": "Metronidazole",
    "formula": "C6H9N3O3",
    "efficacy": "Antibacterial, Antiprotozoal, DNA synthesis inhibitor\nDISEASE   Bacterial vaginosis [DS:H01380]\nTrichomoniasis [DS:H00812]\nIntestinal amebiasis; amebic dysentery [DS:H00360]\nBacterial endocarditis [DS:H00334]\nAnaerobic bacterial infections [DS:H01410]",
    "therapeutic_category": "2529",
    "atc_code": "A01AB17",
    "drug_class": [
      "Antiparasitic",
      "Imidazole antiprotozoal",
      "Metabolizing enzyme substrate",
      "CYP2A6 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2A6"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_2529",
    "type": "category",
    "name_ja": "分類2529",
    "name_en": "",
    "code": "2529"
  },
  {
    "id": "cyp_CYP2A6",
    "type": "cyp",
    "name_en": "CYP2A6",
    "name_ja": "CYP2A6"
  },
  {
    "id": "D00293",
    "type": "drug",
    "name_en": "Diazepam (JP18/USP/INN)",
    "name_ja": "ジアゼパム",
    "names_alt": [
      "Diastat (TN)",
      "Valium (TN)"
    ],
    "search_name": "Diazepam",
    "formula": "C16H13ClN2O",
    "efficacy": "Antianxiety, Antiepileptic, Minor tranquilizer, Sedative-hypnotic\nDISEASE   Anxiety disorders [DS:H01662]",
    "therapeutic_category": "1124",
    "atc_code": "N05BA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Benzodiazepine sedative-hypnotics",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives",
      "Antiepileptic agent",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C19",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      },
      {
        "name": "ふらつき",
        "name_en": "Unsteadiness",
        "frequency": "high"
      },
      {
        "name": "記憶障害",
        "name_en": "Memory impairment",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "cat_1124",
    "type": "category",
    "name_ja": "分類1124",
    "name_en": "",
    "code": "1124"
  },
  {
    "id": "ae_28",
    "type": "adverse_effect",
    "name_ja": "眠気",
    "name_en": "Somnolence"
  },
  {
    "id": "ae_29",
    "type": "adverse_effect",
    "name_ja": "依存性",
    "name_en": "Dependence"
  },
  {
    "id": "ae_30",
    "type": "adverse_effect",
    "name_ja": "ふらつき",
    "name_en": "Unsteadiness"
  },
  {
    "id": "ae_31",
    "type": "adverse_effect",
    "name_ja": "記憶障害",
    "name_en": "Memory impairment"
  },
  {
    "id": "D01514",
    "type": "drug",
    "name_en": "Etizolam (JP18/INN)",
    "name_ja": "エチゾラム",
    "names_alt": [
      "Sedekopan (TN)"
    ],
    "search_name": "Etizolam",
    "formula": "C17H15ClN4S",
    "efficacy": "Antianxiety, Minor tranquilizer, Sedative-hypnotic",
    "therapeutic_category": "1179",
    "atc_code": "N05BA19",
    "drug_class": [
      "Neuropsychiatric agent",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      },
      {
        "name": "ふらつき",
        "name_en": "Unsteadiness",
        "frequency": "high"
      },
      {
        "name": "記憶障害",
        "name_en": "Memory impairment",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "cat_1179",
    "type": "category",
    "name_ja": "分類1179",
    "name_en": "",
    "code": "1179"
  },
  {
    "id": "D00225",
    "type": "drug",
    "name_en": "Alprazolam (JP18/USP/INN)",
    "name_ja": "アルプラゾラム",
    "names_alt": [
      "Xanax (TN)"
    ],
    "search_name": "Alprazolam",
    "formula": "C17H13ClN4",
    "efficacy": "Antianxiety, Minor tranquilizer, Sedative-hypnotic\nDISEASE   Generalized anxiety disorder [DS:H01662]\nPanic disorder [DS:H01664]",
    "therapeutic_category": "1124",
    "atc_code": "N05BA12",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A"
    ],
    "adverse_effects": [
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      },
      {
        "name": "ふらつき",
        "name_en": "Unsteadiness",
        "frequency": "high"
      },
      {
        "name": "記憶障害",
        "name_en": "Memory impairment",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D00365",
    "type": "drug",
    "name_en": "Lorazepam (JP18/USP/INN)",
    "name_ja": "ロラゼパム",
    "names_alt": [
      "Ativan (TN)"
    ],
    "search_name": "Lorazepam",
    "formula": "C15H10Cl2N2O2",
    "efficacy": "Antianxiety, Anticonvulsant, Minor tranquilizer",
    "therapeutic_category": "1124",
    "atc_code": "N05BA06",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Anxiolytics, benzodiazepine derivatives",
      "Antiepileptic agent",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT2B7 substrate",
      "UGT2B15 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      },
      {
        "name": "ふらつき",
        "name_en": "Unsteadiness",
        "frequency": "high"
      },
      {
        "name": "記憶障害",
        "name_en": "Memory impairment",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D00280",
    "type": "drug",
    "name_en": "Clonazepam (JP18/USP/INN)",
    "name_ja": "クロナゼパム",
    "names_alt": [
      "Klonopin (TN)"
    ],
    "search_name": "Clonazepam",
    "formula": "C15H10ClN3O3",
    "efficacy": "Anticonvulsant, Antiepileptic\nDISEASE   Lennox-Gastaut syndrome [DS:H01813]\nPanic disorder [DS:H01664]",
    "therapeutic_category": "1139",
    "atc_code": "N03AE01",
    "drug_class": [
      "Neuropsychiatric agent",
      "GABA-A receptor agonist",
      "Antiepileptic agent",
      "Benzodiazepine derivative, antiepileptic"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      },
      {
        "name": "ふらつき",
        "name_en": "Unsteadiness",
        "frequency": "high"
      },
      {
        "name": "記憶障害",
        "name_en": "Memory impairment",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "cat_1139",
    "type": "category",
    "name_ja": "分類1139",
    "name_en": "",
    "code": "1139"
  },
  {
    "id": "D00706",
    "type": "drug",
    "name_en": "Zolpidem tartrate (JP18/USP)",
    "name_ja": "ゾルピデム",
    "names_alt": [
      "Ambien (TN)",
      "Intermezzo (TN)"
    ],
    "search_name": "Zolpidem",
    "formula": "(C19H21N3O)2. C4H6O6",
    "efficacy": "Sedative-hypnotic\nDISEASE   Insomnia [DS:H01609]",
    "therapeutic_category": "1129",
    "atc_code": "N05CF02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2",
      "CYP2C9",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      },
      {
        "name": "ふらつき",
        "name_en": "Unsteadiness",
        "frequency": "high"
      },
      {
        "name": "記憶障害",
        "name_en": "Memory impairment",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "cat_1129",
    "type": "category",
    "name_ja": "分類1129",
    "name_en": "",
    "code": "1129"
  },
  {
    "id": "D01372",
    "type": "drug",
    "name_en": "Zopiclone (JP18/INN)",
    "name_ja": "ゾピクロン",
    "names_alt": [
      "Amoban (TN)"
    ],
    "search_name": "Zopiclone",
    "formula": "C17H17ClN6O3",
    "efficacy": "Sedative-hypnotic",
    "therapeutic_category": "1129",
    "atc_code": "N05CF01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      },
      {
        "name": "ふらつき",
        "name_en": "Unsteadiness",
        "frequency": "high"
      },
      {
        "name": "記憶障害",
        "name_en": "Memory impairment",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D02624",
    "type": "drug",
    "name_en": "Eszopiclone (JAN/USP/INN)",
    "name_ja": "エスゾピクロン",
    "names_alt": [
      "Estorra (TN)",
      "Lunesta (TN)"
    ],
    "search_name": "Eszopiclone",
    "formula": "C17H17ClN6O3",
    "efficacy": "Sedative-hypnotic\nDISEASE   Insomnia [DS:H01609]",
    "therapeutic_category": "1129",
    "atc_code": "N05CF04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-benzodiazepine sedative-hypnotics",
      "Hypnotic",
      "GABA-A receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP2E1 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2E1",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      },
      {
        "name": "ふらつき",
        "name_en": "Unsteadiness",
        "frequency": "high"
      },
      {
        "name": "記憶障害",
        "name_en": "Memory impairment",
        "frequency": "medium"
      }
    ]
  },
  {
    "id": "D10082",
    "type": "drug",
    "name_en": "Suvorexant (JAN/USAN)",
    "name_ja": "スボレキサント",
    "names_alt": [
      "MK-4305",
      "Belsomra (TN)"
    ],
    "search_name": "Suvorexant",
    "formula": "C23H23ClN6O2",
    "efficacy": "Hypnotic, Orexin receptor antagonist\nDISEASE   Insomnia [DS:H01609]",
    "therapeutic_category": "1190",
    "atc_code": "N05CJ01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Orexin receptor antagonist",
      "Hypnotic",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A",
      "CYP2C19"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_1190",
    "type": "category",
    "name_ja": "分類1190",
    "name_en": "",
    "code": "1190"
  },
  {
    "id": "D11022",
    "type": "drug",
    "name_en": "Lemborexant (JAN/USAN/INN)",
    "name_ja": "レンボレキサント",
    "names_alt": [
      "Dayvigo (TN)"
    ],
    "search_name": "Lemborexant",
    "formula": "C22H20F2N4O2",
    "efficacy": "Hypnotic, Orexin receptor antagonist\nDISEASE   Insomnia [DS:H01609]",
    "therapeutic_category": "1190",
    "atc_code": "N05CJ02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Orexin receptor antagonist",
      "Hypnotic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A5",
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D02689",
    "type": "drug",
    "name_en": "Ramelteon (JAN/USAN/INN)",
    "name_ja": "ラメルテオン",
    "names_alt": [
      "Rozerem (TN)"
    ],
    "search_name": "Ramelteon",
    "formula": "C16H21NO2",
    "efficacy": "Hypnotic, Melatonin receptor agonist\nDISEASE   Insomnia [DS:H01609]",
    "therapeutic_category": "1190",
    "atc_code": "N05CH02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Melatonin receptor agonist",
      "Hypnotic",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00825",
    "type": "drug",
    "name_en": "Sertraline hydrochloride (JAN/USP)",
    "name_ja": "セルトラリン",
    "names_alt": [
      "Zoloft (TN)"
    ],
    "search_name": "Sertraline",
    "formula": "C17H17Cl2N. HCl",
    "efficacy": "Antidepressant, Selective serotonin reuptake inhibitor (SSRI)\nDISEASE   Major depressive disorder [DS:H01646]\nObsessive-compulsive disorder [DS:H01450]\nPanic disorder [DS:H01664]\nSocial anxiety disorder [DS:H01670]",
    "therapeutic_category": "1179",
    "atc_code": "N06AB06",
    "drug_class": [
      "Neuropsychiatric agent",
      "Selective serotonin reuptake inhibitor (SSRI)",
      "Metabolizing enzyme substrate",
      "CYP2B6 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2B6",
      "CYP2C19",
      "CYP2C9",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "悪心",
        "name_en": "Nausea",
        "frequency": "high"
      },
      {
        "name": "性機能障害",
        "name_en": "Sexual dysfunction",
        "frequency": "high"
      },
      {
        "name": "不眠",
        "name_en": "Insomnia",
        "frequency": "medium"
      },
      {
        "name": "セロトニン症候群",
        "name_en": "Serotonin syndrome",
        "frequency": "rare"
      }
    ]
  },
  {
    "id": "ae_32",
    "type": "adverse_effect",
    "name_ja": "悪心",
    "name_en": "Nausea"
  },
  {
    "id": "ae_33",
    "type": "adverse_effect",
    "name_ja": "性機能障害",
    "name_en": "Sexual dysfunction"
  },
  {
    "id": "ae_34",
    "type": "adverse_effect",
    "name_ja": "不眠",
    "name_en": "Insomnia"
  },
  {
    "id": "ae_35",
    "type": "adverse_effect",
    "name_ja": "セロトニン症候群",
    "name_en": "Serotonin syndrome"
  },
  {
    "id": "D02260",
    "type": "drug",
    "name_en": "Paroxetine hydrochloride hemihydrate (USP)",
    "name_ja": "パロキセチン",
    "names_alt": [
      "Paroxetine hydrochloride hydrate (JP18)",
      "Paxil (TN)"
    ],
    "search_name": "Paroxetine",
    "formula": "(C19H20FNO3. HCl)2. H2O",
    "efficacy": "Antidepressant, Selective serotonin reuptake inhibitor (SSRI)\nDISEASE   Major depressive disorder [DS:H01646]\nPanic disorder [DS:H01664]\nSocial anxiety disorder [DS:H01670]",
    "therapeutic_category": "1179",
    "atc_code": "N06AB05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Selective serotonin reuptake inhibitor (SSRI)",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "adverse_effects": [
      {
        "name": "悪心",
        "name_en": "Nausea",
        "frequency": "high"
      },
      {
        "name": "性機能障害",
        "name_en": "Sexual dysfunction",
        "frequency": "high"
      },
      {
        "name": "不眠",
        "name_en": "Insomnia",
        "frequency": "medium"
      },
      {
        "name": "セロトニン症候群",
        "name_en": "Serotonin syndrome",
        "frequency": "rare"
      }
    ]
  },
  {
    "id": "D02567",
    "type": "drug",
    "name_en": "Escitalopram oxalate (JAN/USP)",
    "name_ja": "エスシタロプラム",
    "names_alt": [
      "Lexapro (TN)"
    ],
    "search_name": "Escitalopram",
    "formula": "C20H21FN2O. C2H2O4",
    "efficacy": "Antidepressant, Selective serotonin reuptake inhibitor (SSRI)\nDISEASE   Major depressive disorder [DS:H01646]\nGeneralized anxiety disorder [DS:H01662]",
    "therapeutic_category": "1179",
    "atc_code": "N06AB10",
    "drug_class": [
      "Neuropsychiatric agent",
      "Selective serotonin reuptake inhibitor (SSRI)",
      "Metabolizing enzyme substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "AOX1 substrate",
      "MAO substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2D6",
      "CYP2C19",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "悪心",
        "name_en": "Nausea",
        "frequency": "high"
      },
      {
        "name": "性機能障害",
        "name_en": "Sexual dysfunction",
        "frequency": "high"
      },
      {
        "name": "不眠",
        "name_en": "Insomnia",
        "frequency": "medium"
      },
      {
        "name": "セロトニン症候群",
        "name_en": "Serotonin syndrome",
        "frequency": "rare"
      }
    ]
  },
  {
    "id": "D00824",
    "type": "drug",
    "name_en": "Fluvoxamine maleate (JP18/USP)",
    "name_ja": "フルボキサミン",
    "names_alt": [
      "Luvox (TN)"
    ],
    "search_name": "Fluvoxamine",
    "formula": "C15H21F3N2O2. C4H4O4",
    "efficacy": "Antidepressant, Selective serotonin reuptake inhibitor (SSRI)\nDISEASE   Obsessive compulsive disorder [DS:H01450]",
    "therapeutic_category": "1179",
    "atc_code": "N06AB08",
    "drug_class": [
      "Neuropsychiatric agent",
      "Selective serotonin reuptake inhibitor (SSRI)",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor",
      "CYP2C9 inhibitor",
      "CYP2C19 inhibitor",
      "CYP2D6 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "adverse_effects": [
      {
        "name": "悪心",
        "name_en": "Nausea",
        "frequency": "high"
      },
      {
        "name": "性機能障害",
        "name_en": "Sexual dysfunction",
        "frequency": "high"
      },
      {
        "name": "不眠",
        "name_en": "Insomnia",
        "frequency": "medium"
      },
      {
        "name": "セロトニン症候群",
        "name_en": "Serotonin syndrome",
        "frequency": "rare"
      }
    ]
  },
  {
    "id": "D01179",
    "type": "drug",
    "name_en": "Duloxetine hydrochloride (JAN/USP)",
    "name_ja": "デュロキセチン",
    "names_alt": [
      "Cymbalta (TN)",
      "Yentreve (TN)"
    ],
    "search_name": "Duloxetine",
    "formula": "C18H19NOS. HCl",
    "efficacy": "Antidepressant, Serotonin-noradrenaline reuptake inhibitor (SNRI)\nDISEASE   Major depressive disorder [DS:H01646]\nGeneralized anxiety disorder [DS:H01662]\nDiabetic peripheral neuropathic pain [DS:H01459]\nFibromyalgia [DS:H01636]",
    "therapeutic_category": "1179",
    "atc_code": "N06AX21",
    "drug_class": [
      "Neuropsychiatric agent",
      "Serotonin and norepinephrine reuptake inhibitor (SNRI)",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2D6 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP1A2",
      "CYP2D6"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00821",
    "type": "drug",
    "name_en": "Venlafaxine hydrochloride (JAN/USP)",
    "name_ja": "ベンラファキシン",
    "names_alt": [
      "Effexor (TN)"
    ],
    "search_name": "Venlafaxine",
    "formula": "C17H27NO2. HCl",
    "efficacy": "Antidepressant, Serotonin-noradrenaline reuptake inhibitor (SNRI)\nDISEASE   Major depressive disorder [DS:H01646]\nGeneralized anxiety disorder [DS:H01662]\nSocial anxiety disorder [DS:H01670]\nPanic disorder [DS:H01664]",
    "therapeutic_category": "1179",
    "atc_code": "N06AX16",
    "drug_class": [
      "Neuropsychiatric agent",
      "Serotonin and norepinephrine reuptake inhibitor (SNRI)",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6",
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00563",
    "type": "drug",
    "name_en": "Mirtazapine (JAN/USP/INN)",
    "name_ja": "ミルタザピン",
    "names_alt": [
      "Remeron (TN)",
      "Reflex (TN)"
    ],
    "search_name": "Mirtazapine",
    "formula": "C17H19N3",
    "efficacy": "Antidepressant, Serotonin receptor antagonist\nDISEASE   Major depressive disorder [DS:H01646]",
    "therapeutic_category": "1179",
    "atc_code": "N06AX11",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha2-Adrenergic receptor antagonist",
      "Neuropsychiatric agent",
      "Tetracyclic antidepressant",
      "Noradrenergic and specific serotonergic antidepressant (NaSSA)",
      "Gastrointestinal agent",
      "5-HT3-receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2",
      "CYP2D6",
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00809",
    "type": "drug",
    "name_en": "Amitriptyline hydrochloride (JP18/USP)",
    "name_ja": "アミトリプチリン",
    "names_alt": [
      "Elavil (TN)"
    ],
    "search_name": "Amitriptyline",
    "formula": "C20H23N. HCl",
    "efficacy": "Antidepressant\nDISEASE   Depression [DS:H01646]",
    "therapeutic_category": "1179",
    "atc_code": "N06AA09",
    "drug_class": [
      "Neuropsychiatric agent",
      "Non-selective monoamine reuptake inhibitor",
      "Tricyclic antidepressant",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C19 substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2",
      "CYP2D6",
      "CYP2C19",
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D01164",
    "type": "drug",
    "name_en": "Aripiprazole (JP18/USP/INN)",
    "name_ja": "アリピプラゾール",
    "names_alt": [
      "Abilify (TN)"
    ],
    "search_name": "Aripiprazole",
    "formula": "C23H27Cl2N3O2",
    "efficacy": "Antipsychotic, Dopamine receptor partial agonist, Serotonin receptor agonist/antagonist\nDISEASE   Schizophrenia [DS:H01649]\nBipolar I disorder [DS:H01653]\nMajor depressive disorder [DS:H01646]",
    "therapeutic_category": "1179",
    "atc_code": "N05AX12",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antipsychotic agent",
      "Atypical antipsychotic",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "体重増加",
        "name_en": "Weight gain",
        "frequency": "high"
      },
      {
        "name": "代謝異常",
        "name_en": "Metabolic disorder",
        "frequency": "high"
      },
      {
        "name": "錐体外路症状",
        "name_en": "Extrapyramidal symptoms",
        "frequency": "medium"
      },
      {
        "name": "QT延長",
        "name_en": "QT prolongation",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "ae_36",
    "type": "adverse_effect",
    "name_ja": "体重増加",
    "name_en": "Weight gain"
  },
  {
    "id": "ae_37",
    "type": "adverse_effect",
    "name_ja": "代謝異常",
    "name_en": "Metabolic disorder"
  },
  {
    "id": "ae_38",
    "type": "adverse_effect",
    "name_ja": "錐体外路症状",
    "name_en": "Extrapyramidal symptoms"
  },
  {
    "id": "D00454",
    "type": "drug",
    "name_en": "Olanzapine (JAN/USP/INN)",
    "name_ja": "オランザピン",
    "names_alt": [
      "Zyprexa (TN)"
    ],
    "search_name": "Olanzapine",
    "formula": "C17H20N4S",
    "efficacy": "Antipsychotic\nDISEASE   Schizophrenia [DS:H01649]\nBipolar I disorder, manic or mixed episodes [DS:H01653]",
    "therapeutic_category": "1179",
    "atc_code": "N05AH03",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist",
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Antipsychotic agent",
      "Atypical antipsychotic",
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2",
      "CYP2D6"
    ],
    "adverse_effects": [
      {
        "name": "体重増加",
        "name_en": "Weight gain",
        "frequency": "high"
      },
      {
        "name": "代謝異常",
        "name_en": "Metabolic disorder",
        "frequency": "high"
      },
      {
        "name": "錐体外路症状",
        "name_en": "Extrapyramidal symptoms",
        "frequency": "medium"
      },
      {
        "name": "QT延長",
        "name_en": "QT prolongation",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "D00458",
    "type": "drug",
    "name_en": "Quetiapine fumarate (JP18/USP)",
    "name_ja": "クエチアピン",
    "names_alt": [
      "Seroquel (TN)"
    ],
    "search_name": "Quetiapine",
    "formula": "(C21H25N3O2S)2. C4H4O4",
    "efficacy": "Antipsychotic\nDISEASE   Schizophrenia [DS:H01649]\nBipolar disorder [DS:H01653]",
    "therapeutic_category": "1179",
    "atc_code": "N05AH04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Atypical antipsychotic",
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "体重増加",
        "name_en": "Weight gain",
        "frequency": "high"
      },
      {
        "name": "代謝異常",
        "name_en": "Metabolic disorder",
        "frequency": "high"
      },
      {
        "name": "錐体外路症状",
        "name_en": "Extrapyramidal symptoms",
        "frequency": "medium"
      },
      {
        "name": "QT延長",
        "name_en": "QT prolongation",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "D00426",
    "type": "drug",
    "name_en": "Risperidone (JP18/USP/INN)",
    "name_ja": "リスペリドン",
    "names_alt": [
      "Risperdal (TN)"
    ],
    "search_name": "Risperidone",
    "formula": "C23H27FN4O2",
    "efficacy": "Antipsychotic, Neuroleptic\nDISEASE   Schizophrenia [DS:H01649]\nBipolar mania [DS:H01653]",
    "therapeutic_category": "1179",
    "atc_code": "N05AX08",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Serotonin-dopamine antagonist (SDA)",
      "Antipsychotic agent",
      "Atypical antipsychotic",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "体重増加",
        "name_en": "Weight gain",
        "frequency": "high"
      },
      {
        "name": "代謝異常",
        "name_en": "Metabolic disorder",
        "frequency": "high"
      },
      {
        "name": "錐体外路症状",
        "name_en": "Extrapyramidal symptoms",
        "frequency": "medium"
      },
      {
        "name": "QT延長",
        "name_en": "QT prolongation",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "D00136",
    "type": "drug",
    "name_en": "Haloperidol (JP18/USP/INN)",
    "name_ja": "ハロペリドール",
    "names_alt": [
      "Haldol (TN)"
    ],
    "search_name": "Haloperidol",
    "formula": "C21H23ClFNO2",
    "efficacy": "Antipsychotic, Antidyskinetic, Neuroleptic, Dopamine D2 receptor antagonist\nDISEASE   Tourette’s disorder [DS:H00862]",
    "therapeutic_category": "1179",
    "atc_code": "N05AD01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine antagonist",
      "Dopamine D2-receptor antagonist",
      "Antipsychotic agent",
      "Butyrophenone derivative",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "体重増加",
        "name_en": "Weight gain",
        "frequency": "high"
      },
      {
        "name": "代謝異常",
        "name_en": "Metabolic disorder",
        "frequency": "high"
      },
      {
        "name": "錐体外路症状",
        "name_en": "Extrapyramidal symptoms",
        "frequency": "medium"
      },
      {
        "name": "QT延長",
        "name_en": "QT prolongation",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "D00801",
    "type": "drug",
    "name_en": "Lithium carbonate (JP18/USP)",
    "name_ja": "炭酸リチウム",
    "names_alt": [
      "Eskalith (TN)",
      "Lithobid (TN)"
    ],
    "search_name": "Lithium carbonate",
    "formula": "CO3. 2Li",
    "efficacy": "Antimanic\nDISEASE   Bipolar disorder, manic episodes [DS:H01653]",
    "therapeutic_category": "1179",
    "atc_code": "N05AN01",
    "drug_class": [],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00399",
    "type": "drug",
    "name_en": "Valproic acid (USP)",
    "name_ja": "バルプロ酸",
    "names_alt": [
      "Depakene (TN)"
    ],
    "search_name": "Valproic acid",
    "formula": "C8H16O2",
    "efficacy": "Anticonvulsant",
    "therapeutic_category": "",
    "atc_code": "N03AG01",
    "drug_class": [
      "Cardiovascular agent",
      "Calcium channel blocker",
      "Calcium channel T type blocker",
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Fatty acid antiepileptic"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00252",
    "type": "drug",
    "name_en": "Carbamazepine (JP18/USP/INN)",
    "name_ja": "カルバマゼピン",
    "names_alt": [
      "Equetro (TN)",
      "Tegretol (TN)"
    ],
    "search_name": "Carbamazepine",
    "formula": "C15H12N2O",
    "efficacy": "Analgesic, Antiepileptic\nDISEASE   Trigeminal neuralgia [DS:H01638]",
    "therapeutic_category": "1139",
    "atc_code": "N03AF01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Carboxamide antiepileptic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer",
      "Transporter inducer",
      "ABCB1 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "高カリウム血症",
        "name_en": "Hyperkalemia",
        "frequency": "medium"
      },
      {
        "name": "めまい",
        "name_en": "Dizziness",
        "frequency": "medium"
      },
      {
        "name": "腎機能障害",
        "name_en": "Renal impairment",
        "frequency": "low"
      }
    ]
  },
  {
    "id": "D00354",
    "type": "drug",
    "name_en": "Lamotrigine (JAN/USP/INN)",
    "name_ja": "ラモトリギン",
    "names_alt": [
      "Lamictal (TN)"
    ],
    "search_name": "Lamotrigine",
    "formula": "C9H7Cl2N5",
    "efficacy": "Anti-bipolar disorder, Anticonvulsant, Antiepileptic\nDISEASE   Lennox-Gastaut syndrome [DS:H01813]\nBipolar disorder [DS:H01653]",
    "therapeutic_category": "1139",
    "atc_code": "N03AX09",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "Metabolizing enzyme substrate",
      "UGT substrate",
      "UGT1A4 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00059",
    "type": "drug",
    "name_en": "Levodopa (JP18/USP/INN)",
    "name_ja": "レボドパ",
    "names_alt": [
      "Dopar (TN)"
    ],
    "search_name": "Levodopa",
    "formula": "C9H11NO4",
    "efficacy": "Antiparkinsonian\nDISEASE   Parkinson disease [DS:H00057]\nParkinsonism [DS:H01600]",
    "therapeutic_category": "1164",
    "atc_code": "N04BA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine agonist",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_1164",
    "type": "category",
    "name_ja": "分類1164",
    "name_en": "",
    "code": "1164"
  },
  {
    "id": "D00559",
    "type": "drug",
    "name_en": "Pramipexole dihydrochloride (USP)",
    "name_ja": "プラミペキソール",
    "names_alt": [
      "Pramipexole hydrochloride hydrate (JAN)",
      "Pramipexole dihydrochloride monohydrate",
      "Mirapex (TN)"
    ],
    "search_name": "Pramipexole",
    "formula": "C10H17N3S. 2HCl. H2O",
    "efficacy": "Antidepressant, Antiparkinsonian, Dopamine receptor agonist\nDISEASE   Parkinson disease [DS:H00057]\nRestless legs syndrome [DS:H01597]",
    "therapeutic_category": "1169",
    "atc_code": "N04BC05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine agonist",
      "Antiparkinson agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_1169",
    "type": "category",
    "name_ja": "分類1169",
    "name_en": "",
    "code": "1169"
  },
  {
    "id": "D00784",
    "type": "drug",
    "name_en": "Ropinirole hydrochloride (JAN/USP)",
    "name_ja": "ロピニロール",
    "names_alt": [
      "Requip (TN)"
    ],
    "search_name": "Ropinirole",
    "formula": "C16H24N2O. HCl",
    "efficacy": "Antiparkinsonian, Dopamine receptor agonist\nDISEASE   Parkinson disease [DS:H00057]\nRestless legs syndrome [DS:H01597]",
    "therapeutic_category": "1169",
    "atc_code": "N04BC04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Dopamine agonist",
      "Dopamine D2-receptor agonist",
      "Antiparkinson agent",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00670",
    "type": "drug",
    "name_en": "Donepezil hydrochloride (JP18/USP)",
    "name_ja": "ドネペジル",
    "names_alt": [
      "Aricept (TN)"
    ],
    "search_name": "Donepezil",
    "formula": "C24H29NO3. HCl",
    "efficacy": "Dementia therapeutic agent, Acetylcholinesterase inhibitor\nDISEASE   Dementia of the Alzheimer's type [DS:H00056]",
    "therapeutic_category": "1190",
    "atc_code": "N06DA02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Cholinesterase inhibitor",
      "Acetylcholinesterase inhibitor",
      "Antidementia agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6",
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00529",
    "type": "drug",
    "name_en": "Montelukast sodium (JP18/USP)",
    "name_ja": "モンテルカスト",
    "names_alt": [
      "Singulair (TN)"
    ],
    "search_name": "Montelukast",
    "formula": "C35H35ClNO3S. Na",
    "efficacy": "Antiallergic, Antiasthmatic, Leukotriene receptor antagonist\nDISEASE   Asthma [DS:H00079]\nAllergic rhinitis [DS:H01360]",
    "therapeutic_category": "4490",
    "atc_code": "R03DC03",
    "drug_class": [
      "Anti-allergic agent",
      "Cysteinyl leukotriene receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C9",
      "CYP2C8",
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_4490",
    "type": "category",
    "name_ja": "分類4490",
    "name_en": "",
    "code": "4490"
  },
  {
    "id": "D02732",
    "type": "drug",
    "name_en": "Pranlukast hydrate (JP18)",
    "name_ja": "プランルカスト",
    "names_alt": [
      "Onon (TN)"
    ],
    "search_name": "Pranlukast",
    "formula": "(C27H23N5O4)2. H2O",
    "efficacy": "Antiallergic, Antiasthmatic, Anti-inflammatory, Leukotriene receptor antagonist",
    "therapeutic_category": "4490",
    "atc_code": "R03DC02",
    "drug_class": [
      "Anti-allergic agent",
      "Cysteinyl leukotriene receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00371",
    "type": "drug",
    "name_en": "Theophylline (JP18)",
    "name_ja": "テオフィリン",
    "names_alt": [
      "Elixophyllin (TN)",
      "Quibron-t (TN)",
      "Theo-24 (TN)",
      "Theodur G (TN)",
      "Theolair (TN)",
      "Uniphyl (TN)"
    ],
    "search_name": "Theophylline",
    "formula": "C7H8N4O2",
    "efficacy": "Bronchodilator, Phosphodiesterase inhibitor\nDISEASE   Chronic asthma [DS:H00079]",
    "therapeutic_category": "2251",
    "atc_code": "R03DA04",
    "drug_class": [
      "Respiratory system agent",
      "Xanthine derivative",
      "Xanthine-type bronchodilator",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_2251",
    "type": "category",
    "name_ja": "分類2251",
    "name_en": "",
    "code": "2251"
  },
  {
    "id": "D00246",
    "type": "drug",
    "name_en": "Budesonide (JP18/USP/INN)",
    "name_ja": "ブデソニド",
    "names_alt": [
      "Entocort EC (TN)",
      "Pulmicort (TN)",
      "Rhinocort (TN)",
      "Uceris (TN)"
    ],
    "search_name": "Budesonide",
    "formula": "C25H34O6",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Asthma [DS:H00079]\nCrohn's disease [DS:H00286]\nPerennial allergic rhinitis [DS:H01360]\nDistal ulcerative colitis [DS:H01466]",
    "therapeutic_category": "2290",
    "atc_code": "A07EA06",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_2290",
    "type": "category",
    "name_ja": "分類2290",
    "name_en": "",
    "code": "2290"
  },
  {
    "id": "D01708",
    "type": "drug",
    "name_en": "Fluticasone propionate (JAN/USP)",
    "name_ja": "フルチカゾン",
    "names_alt": [
      "Cutivate (TN)",
      "Flonase (TN)",
      "Flovent (TN)"
    ],
    "search_name": "Fluticasone",
    "formula": "C25H31F3O5S",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Asthma [DS:H00079]",
    "therapeutic_category": "1329",
    "atc_code": "D07AC17",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_1329",
    "type": "category",
    "name_ja": "分類1329",
    "name_en": "",
    "code": "1329"
  },
  {
    "id": "D00689",
    "type": "drug",
    "name_en": "Beclomethasone dipropionate (USP)",
    "name_ja": "ベクロメタゾン",
    "names_alt": [
      "Beclometasone dipropionate (JP18)",
      "Beclovent (TN)",
      "Qnasl (TN)",
      "Vanceril (TN)"
    ],
    "search_name": "Beclomethasone",
    "formula": "C28H37ClO7",
    "efficacy": "Antiasthmatic, Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Asthma [DS:H00079]\nAllergic rhinitis [DS:H01360]",
    "therapeutic_category": "1329",
    "atc_code": "A07EA07",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D01929",
    "type": "drug",
    "name_en": "Tiotropium bromide hydrate (JAN)",
    "name_ja": "チオトロピウム",
    "names_alt": [
      "Tiotropium bromide monohydrate",
      "Spiriva (TN)"
    ],
    "search_name": "Tiotropium",
    "formula": "C19H22NO4S2. Br. H2O",
    "efficacy": "Bronchodilator, Muscarinic acetylcholine receptor antagonist\nDISEASE   Chronic obstructive pulmonary disease [DS:H01714]\nAsthma [DS:H00079]",
    "therapeutic_category": "2259",
    "atc_code": "R03BB04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2259",
    "type": "category",
    "name_ja": "分類2259",
    "name_en": "",
    "code": "2259"
  },
  {
    "id": "D00687",
    "type": "drug",
    "name_en": "Salmeterol xinafoate (JAN/USP)",
    "name_ja": "サルメテロール",
    "names_alt": [
      "Serevent (TN)"
    ],
    "search_name": "Salmeterol",
    "formula": "C25H37NO4. C11H8O3",
    "efficacy": "Bronchodilator, beta2-Adrenergic receptor agonist\nDISEASE   Asthma [DS:H00079]\nChronic obstructive pulmonary disease [DS:H01714]",
    "therapeutic_category": "2259",
    "atc_code": "R03AC12",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D01373",
    "type": "drug",
    "name_en": "Formoterol fumarate (USP)",
    "name_ja": "ホルモテロール",
    "names_alt": [
      "Foradil (TN)"
    ],
    "search_name": "Formoterol",
    "formula": "(C19H24N2O4)2. C4H4O4",
    "efficacy": "Bronchodilator, beta2-Adrenergic receptor agonist\nDISEASE   Asthma [DS:H00079]\nChronic obstructive pulmonary disease [DS:H01714]",
    "therapeutic_category": "",
    "atc_code": "R03AC13",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta2-Adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00195",
    "type": "drug",
    "name_en": "Codeine (USP)",
    "name_ja": "コデイン",
    "names_alt": [
      "Codeine hydrate"
    ],
    "search_name": "Codeine",
    "formula": "C18H21NO3. H2O",
    "efficacy": "Analgesic (narcotic), Antitussive, Opioid receptor agonist",
    "therapeutic_category": "",
    "atc_code": "R05DA04",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate",
      "UGT2B4 substrate",
      "UGT2B7 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "便秘",
        "name_en": "Constipation",
        "frequency": "high"
      },
      {
        "name": "悪心・嘔吐",
        "name_en": "Nausea/vomiting",
        "frequency": "high"
      },
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "呼吸抑制",
        "name_en": "Respiratory depression",
        "frequency": "medium"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      }
    ]
  },
  {
    "id": "ae_39",
    "type": "adverse_effect",
    "name_ja": "便秘",
    "name_en": "Constipation"
  },
  {
    "id": "ae_40",
    "type": "adverse_effect",
    "name_ja": "悪心・嘔吐",
    "name_en": "Nausea/vomiting"
  },
  {
    "id": "ae_41",
    "type": "adverse_effect",
    "name_ja": "呼吸抑制",
    "name_en": "Respiratory depression"
  },
  {
    "id": "D00848",
    "type": "drug",
    "name_en": "Dextromethorphan hydrobromide (USP)",
    "name_ja": "デキストロメトルファン",
    "names_alt": [
      "Dextromethorphan hydrobromide hydrate (JP18)",
      "Benylin DM (TN)"
    ],
    "search_name": "Dextromethorphan",
    "formula": "C18H25NO. HBr. H2O",
    "efficacy": "Antitussive",
    "therapeutic_category": "2223",
    "atc_code": "R05DA09",
    "drug_class": [
      "Neuropsychiatric agent",
      "NMDA receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_2223",
    "type": "category",
    "name_ja": "分類2223",
    "name_en": "",
    "code": "2223"
  },
  {
    "id": "D00671",
    "type": "drug",
    "name_en": "Fexofenadine hydrochloride (JP18/USP)",
    "name_ja": "フェキソフェナジン",
    "names_alt": [
      "Allegra (TN)"
    ],
    "search_name": "Fexofenadine",
    "formula": "C32H39NO4. HCl",
    "efficacy": "Antiallergic, H1 receptor antagonist\nDISEASE   Seasonal allergic rhinitis [DS:H01360]",
    "therapeutic_category": "4490",
    "atc_code": "R06AX26",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00664",
    "type": "drug",
    "name_en": "Cetirizine hydrochloride (JP18/USP)",
    "name_ja": "セチリジン",
    "names_alt": [
      "Zyrtec (TN)"
    ],
    "search_name": "Cetirizine",
    "formula": "C21H25ClN2O3. 2HCl",
    "efficacy": "Antiallergic, H1 receptor antagonist",
    "therapeutic_category": "4490",
    "atc_code": "R06AE07",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Transporter substrate",
      "ABCB1 substrate",
      "SLC22A2 substrate",
      "Transporter inhibitor",
      "SLC22A2 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00364",
    "type": "drug",
    "name_en": "Loratadine (JAN/USP/INN)",
    "name_ja": "ロラタジン",
    "names_alt": [
      "Claritin (TN)"
    ],
    "search_name": "Loratadine",
    "formula": "C22H23ClN2O2",
    "efficacy": "Antiallergic, H1 receptor antagonist",
    "therapeutic_category": "4490",
    "atc_code": "R06AX13",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6",
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D03693",
    "type": "drug",
    "name_en": "Desloratadine (JAN/USP/INN)",
    "name_ja": "デスロラタジン",
    "names_alt": [
      "Clarinex (TN)"
    ],
    "search_name": "Desloratadine",
    "formula": "C19H19ClN2",
    "efficacy": "Antiallergic, Antipruritic, H1 receptor antagonist\nDISEASE   Allergic rhinitis [DS:H01360]",
    "therapeutic_category": "4490",
    "atc_code": "R06AX27",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D01192",
    "type": "drug",
    "name_en": "Olopatadine hydrochloride (JP18/USP)",
    "name_ja": "オロパタジン",
    "names_alt": [
      "Allelock (TN)",
      "Patanol (TN)",
      "Opatanol (TN)"
    ],
    "search_name": "Olopatadine",
    "formula": "C21H23NO3. HCl",
    "efficacy": "Antiallergic, H1 receptor antagonist\nDISEASE   Seasonal allergic rhinitis [DS:H01360]",
    "therapeutic_category": "1319",
    "atc_code": "R01AC08",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D01654",
    "type": "drug",
    "name_en": "Bepotastine besylate (USAN)",
    "name_ja": "ベポタスチン",
    "names_alt": [
      "Bepotastine besilate (JP18)",
      "Bepreve (TN)",
      "Talion (TN)"
    ],
    "search_name": "Bepotastine",
    "formula": "C21H25ClN2O3. C6H6O3S",
    "efficacy": "Antiallergic, Antipruritic, H1 receptor antagonist",
    "therapeutic_category": "4490",
    "atc_code": "",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D09570",
    "type": "drug",
    "name_en": "Bilastine (JAN/INN)",
    "name_ja": "ビラスチン",
    "names_alt": [
      "Bilanoa (TN)"
    ],
    "search_name": "Bilastine",
    "formula": "C28H37N3O3",
    "efficacy": "Antiallergic, Antipruritic, H1 receptor antagonist",
    "therapeutic_category": "4490",
    "atc_code": "R06AX29",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D01713",
    "type": "drug",
    "name_en": "Epinastine hydrochloride (JAN)",
    "name_ja": "エピナスチン",
    "names_alt": [
      "Alesion (TN)",
      "Elestat (TN)"
    ],
    "search_name": "Epinastine",
    "formula": "C16H15N3. HCl",
    "efficacy": "Antiallergic, H1 receptor antagonist",
    "therapeutic_category": "1319",
    "atc_code": "R06AX24",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00407",
    "type": "drug",
    "name_en": "Methylprednisolone (JP18/USP/INN)",
    "name_ja": "プレドニゾロン",
    "names_alt": [
      "Medrol (TN)"
    ],
    "search_name": "Prednisolone",
    "formula": "C22H30O5",
    "efficacy": "Antiallergic, Anti-inflammatory, Glucocorticoid receptor agonist\nDISEASE   Congenital adrenal hyperplasia [DS:H00216]\nRheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nAnkylosing spondylitis [DS:H01674]\nPsoriatic arthritis [DS:H01507]\nSystemic lupus erythematosus [DS:H00080]\nSystemic dermatomyositis and polymyositis [DS:H01604]\nBullous dermatitis herpetiformis [DS:H01362]\nErythema multiforme [DS:H01695]\nStevens-Johnson syndrome [DS:H01694]\nSeborrheic dermatitis [DS:H01652]\nMycosis fungoides [DS:H01463]\nPemphigus [DS:H01648]\nSevere psoriasis [DS:H01656]\nSeasonal or perennial allergic rhinitis [DS:H01360]\nContact dermatitis [DS:H01357]\nBronchial asthma [DS:H00079]\nAtopic dermatitis [DS:H01358]\nOptic neuritis [DS:H01717]\nPulmonary tuberculosis [DS:H00342]\nAcquired (autoimmune) hemolytic anemia [DS:H01585]\nNephrotic syndrome [DS:H01657]\nUlcerative colitis [DS:H01466]\nMultiple sclerosis [DS:H01490]",
    "therapeutic_category": "2456",
    "atc_code": "D07AA01",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_2456",
    "type": "category",
    "name_ja": "分類2456",
    "name_en": "",
    "code": "2456"
  },
  {
    "id": "D00292",
    "type": "drug",
    "name_en": "Dexamethasone (JP18/USP/INN)",
    "name_ja": "デキサメタゾン",
    "names_alt": [
      "Decadron (TN)",
      "Maxidex (TN)"
    ],
    "search_name": "Dexamethasone",
    "formula": "C22H29FO5",
    "efficacy": "Anti-inflammatory, Antipruritic, Glucocorticoid receptor agonist\nDISEASE   Diabetic macular edema [DS:H01651]\nAsthma [DS:H00079]\nAtopic dermatitis [DS:H01358]\nContact dermatitis [DS:H01357]\nAllergic rhinitis [DS:H01360]\nBullous dermatitis herpetiformis [DS:H01362]\nMycosis fungoides [DS:H01463]\nPemphigus [DS:H01648]\nErythema multiforme [DS:H01695]\nStevens-Johnson syndrome [DS:H01694]\nCongenital adrenal hyperplasia [DS:H00216]\nUlcerative colitis [DS:H01466]\nAcquired (autoimmune) hemolytic anemia [DS:H01585]\nCongenital (erythroid) hypoplastic anemia; Diamond-Blackfan anemia [DS:H00237]\nPure red cell aplasia [DS:H01586]\nMultiple sclerosis [DS:H01490]\nTemporal arteritis [DS:H01698]\nNephrotic syndrome [DS:H01657]\nPulmonary tuberculosis [DS:H00342]\nAcute gouty arthritis [DS:H01532]\nAnkylosing spondylitis [DS:H01674]\nPsoriatic arthritis [DS:H01507]\nRheumatoid arthritis [DS:H00630]\nJuvenile rheumatoid arthritis [DS:H01672]\nDermatomyositis and polymyositis [DS:H01604]\nSystemic lupus erythematosus [DS:H00080]",
    "therapeutic_category": "1315",
    "atc_code": "A01AC02",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inducer",
      "CYP3A/CYP3A4 inducer",
      "CYP3A4 inducer"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_1315",
    "type": "category",
    "name_ja": "分類1315",
    "name_en": "",
    "code": "1315"
  },
  {
    "id": "D00244",
    "type": "drug",
    "name_en": "Betamethasone (JP18/USP/INN)",
    "name_ja": "ベタメタゾン",
    "names_alt": [
      "Celestone (TN)",
      "Rinderon (TN)"
    ],
    "search_name": "Betamethasone",
    "formula": "C22H29FO5",
    "efficacy": "Anti-inflammatory, Antirheumatic, Glucocorticoid receptor agonist",
    "therapeutic_category": "2454",
    "atc_code": "A07EA04",
    "drug_class": [
      "Anti-inflammatory",
      "Corticosteroid",
      "Glucocorticoid",
      "Dermatological agent",
      "Atopic dermatitis agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2454",
    "type": "category",
    "name_ja": "分類2454",
    "name_en": "",
    "code": "2454"
  },
  {
    "id": "D01024",
    "type": "drug",
    "name_en": "Tamsulosin hydrochloride (JP18/USP)",
    "name_ja": "タムスロシン",
    "names_alt": [
      "Flomax (TN)",
      "Harnal (TN)"
    ],
    "search_name": "Tamsulosin",
    "formula": "C20H28N2O5S. HCl",
    "efficacy": "Antidysuria, alpha1-Adrenergic receptor antagonist",
    "therapeutic_category": "2590",
    "atc_code": "G04CA02",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2590",
    "type": "category",
    "name_ja": "分類2590",
    "name_en": "",
    "code": "2590"
  },
  {
    "id": "D01965",
    "type": "drug",
    "name_en": "Silodosin (JP18/INN)",
    "name_ja": "シロドシン",
    "names_alt": [
      "KMD 3213",
      "Rapaflo (TN)",
      "Urief (TN)"
    ],
    "search_name": "Silodosin",
    "formula": "C25H32F3N3O4",
    "efficacy": "Antidysuria, alpha1-Adrenergic receptor antagonist",
    "therapeutic_category": "2590",
    "atc_code": "G04CA04",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D01674",
    "type": "drug",
    "name_en": "Naftopidil (JP18/INN)",
    "name_ja": "ナフトピジル",
    "names_alt": [
      "Flivas (TN)"
    ],
    "search_name": "Naftopidil",
    "formula": "C24H28N2O3",
    "efficacy": "Antidysuria, alpha1-Adrenergic receptor antagonist",
    "therapeutic_category": "2590",
    "atc_code": "",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor antagonist",
      "alpha-Adrenergic receptor antagonist",
      "alpha1-Adrenergic receptor antagonist"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D03820",
    "type": "drug",
    "name_en": "Dutasteride (JAN/USP/INN)",
    "name_ja": "デュタステリド",
    "names_alt": [
      "Avodart (TN)"
    ],
    "search_name": "Dutasteride",
    "formula": "C27H30F6N2O2",
    "efficacy": "Prostatic hyperplasia treatment, Antiandrogen, 5alpha-Reductase inhibitor",
    "therapeutic_category": "2499",
    "atc_code": "G04CB02",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "CYP3A5 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A5",
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00321",
    "type": "drug",
    "name_en": "Finasteride (JAN/USP/INN)",
    "name_ja": "フィナステリド",
    "names_alt": [
      "Propecia (TN)",
      "Proscar (TN)"
    ],
    "search_name": "Finasteride",
    "formula": "C23H36N2O2",
    "efficacy": "Antiandrogen, 5alpha-Reductase inhibitor",
    "therapeutic_category": "2499",
    "atc_code": "D11AX10",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D09535",
    "type": "drug",
    "name_en": "Mirabegron (JAN/USAN/INN)",
    "name_ja": "ミラベグロン",
    "names_alt": [
      "Myrbetriq (TN)"
    ],
    "search_name": "Mirabegron",
    "formula": "C21H24N4O2S",
    "efficacy": "Overactive bladder agent, beta3-Adrenergic receptor agonist",
    "therapeutic_category": "2590",
    "atc_code": "G04BD12",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta3-Adrenergic receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D01269",
    "type": "drug",
    "name_en": "Solifenacin succinate (JAN/USAN/INN)",
    "name_ja": "ソリフェナシン",
    "names_alt": [
      "Vesicare (TN)"
    ],
    "search_name": "Solifenacin",
    "formula": "C23H26N2O2. C4H6O4",
    "efficacy": "Overactive bladder agent, Muscarinic acetylcholine receptor antagonist",
    "therapeutic_category": "2590",
    "atc_code": "G04BD08",
    "drug_class": [
      "Neuropsychiatric agent",
      "Muscarinic cholinergic receptor antagonist",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D02008",
    "type": "drug",
    "name_en": "Tadalafil (JAN/USP/INN)",
    "name_ja": "タダラフィル",
    "names_alt": [
      "Adcirca (TN)",
      "Cialis (TN)",
      "Zalutia (TN)"
    ],
    "search_name": "Tadalafil",
    "formula": "C22H19N3O4",
    "efficacy": "Antihypertensive, Impotence therapy, Phosphodiesterase V inhibitor\nDISEASE   Pulmonary arterial hypertension [DS:H01621]",
    "therapeutic_category": "2190",
    "atc_code": "G04BE08",
    "drug_class": [
      "Cardiovascular agent",
      "Phosphodiesterase V inhibitor",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00939",
    "type": "drug",
    "name_en": "Alendronate sodium (USP)",
    "name_ja": "アレンドロン酸",
    "names_alt": [
      "Alendronate sodium hydrate (JP18)",
      "Binosto (TN)",
      "Fosamax (TN)"
    ],
    "search_name": "Alendronate",
    "formula": "C4H12NO7P2. 3H2O. Na",
    "efficacy": "Antiresorptive, Osteoporosis agent, Farnesylpyrophosphate synthetase inhibitor\nDISEASE   Osteoporosis [DS:H01593]\nGlucocorticoid-induced osteoporosis [DS:H01709]\nPaget's disease of bone [DS:H00437]",
    "therapeutic_category": "3999",
    "atc_code": "M05BA04",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Osteoporosis agent",
      "Bisphosphonate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_3999",
    "type": "category",
    "name_ja": "分類3999",
    "name_en": "",
    "code": "3999"
  },
  {
    "id": "D00942",
    "type": "drug",
    "name_en": "Risedronate sodium (USP)",
    "name_ja": "リセドロン酸",
    "names_alt": [
      "Actonel (TN)"
    ],
    "search_name": "Risedronate",
    "formula": "C7H10NO7P2. Na",
    "efficacy": "Antiresorptive, Osteoporosis agent, Farnesylpyrophosphate synthetase inhibitor\nDISEASE   Osteoporosis [DS:H01593]\nGlucocorticoid-induced osteoporosis [DS:H01709]\nPaget's disease of bone [DS:H00437]",
    "therapeutic_category": "",
    "atc_code": "M05BA07",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Osteoporosis agent",
      "Bisphosphonate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D03684",
    "type": "drug",
    "name_en": "Denosumab (USAN)",
    "name_ja": "デノスマブ",
    "names_alt": [
      "Denosumab (genetical recombination) (JAN)",
      "Denosumab (genetical recombination) [Denosumab biosimilar 1] (JAN)",
      "Denosumab-dssb",
      "Denosumab-bmwo",
      "Ospomyv (TN)",
      "Prolia (TN)",
      "Ranmark (TN)",
      "Xbryk (TN)",
      "Xgeva (TN)"
    ],
    "search_name": "Denosumab",
    "formula": "C6404H9912N1724O2004S50",
    "efficacy": "Osteoporosis agent, Anti-RANKL antibody\nDISEASE   Osteoporosis [DS:H01593]\nMultiple myeloma [DS:H00010]\nGiant cell tumor of bone [DS:H01470]\nTYPE      Monoclonal antibody",
    "therapeutic_category": "3999",
    "atc_code": "M05BX04",
    "drug_class": [
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D07578",
    "type": "drug",
    "name_en": "Eldecalcitol (JAN/INN)",
    "name_ja": "エルデカルシトール",
    "names_alt": [
      "Edirol (TN)"
    ],
    "search_name": "Eldecalcitol",
    "formula": "C30H50O5",
    "efficacy": "Antipsoriatic, Osteoporosis agent, Vitamin D receptor agonist",
    "therapeutic_category": "3112",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Vitamin D derivatives",
      "Activated vitamin D3",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_3112",
    "type": "category",
    "name_ja": "分類3112",
    "name_en": "",
    "code": "3112"
  },
  {
    "id": "D01518",
    "type": "drug",
    "name_en": "Alfacalcidol (JAN/INN)",
    "name_ja": "アルファカルシドール",
    "names_alt": [
      "Alsiodol (TN)"
    ],
    "search_name": "Alfacalcidol",
    "formula": "C27H44O2",
    "efficacy": "Osteoporosis agent, Vitamin D receptor agonist",
    "therapeutic_category": "3112",
    "atc_code": "A11CC03",
    "drug_class": [
      "Gastrointestinal agent",
      "Vitamin D derivatives",
      "Activated vitamin D3",
      "Musculo-skeletal system agent",
      "Osteoporosis agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D01010",
    "type": "drug",
    "name_en": "Levothyroxine sodium (USP)",
    "name_ja": "レボチロキシン",
    "names_alt": [
      "Levothyroxine sodium hydrate (JP18)",
      "Levothroid (TN)",
      "Levoxyl (TN)",
      "Synthroid (TN)"
    ],
    "search_name": "Levothyroxine",
    "formula": "C15H10I4NO4. Na. xH2O",
    "efficacy": "Replenisher (thyroid hormone)\nDISEASE   Hypothyroidism [DS:H00250]\nHashimoto's thyroiditis [DS:H00081]",
    "therapeutic_category": "2431",
    "atc_code": "H03AA01",
    "drug_class": [
      "Hormonal agent",
      "Thyroid preparation",
      "Thyroid hormone replenisher"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2431",
    "type": "category",
    "name_ja": "分類2431",
    "name_en": "",
    "code": "2431"
  },
  {
    "id": "D00401",
    "type": "drug",
    "name_en": "Methimazole (USP)",
    "name_ja": "チアマゾール",
    "names_alt": [
      "Thiamazole (JP18/INN)",
      "Tapazole (TN)"
    ],
    "search_name": "Thiamazole",
    "formula": "C4H6N2S",
    "efficacy": "Antithyroid, Thyroid hormone synthesis inhibitor\nDISEASE   Graves' disease [DS:H00082]\nHyperthyroidism [DS:H01645]",
    "therapeutic_category": "2432",
    "atc_code": "H03BB02",
    "drug_class": [
      "Hormonal agent",
      "Antithyroid agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2432",
    "type": "category",
    "name_ja": "分類2432",
    "name_en": "",
    "code": "2432"
  },
  {
    "id": "D00224",
    "type": "drug",
    "name_en": "Allopurinol (JP18/USP/INN)",
    "name_ja": "アロプリノール",
    "names_alt": [
      "Zyloprim (TN)"
    ],
    "search_name": "Allopurinol",
    "formula": "C5H4N4O",
    "efficacy": "Gout suppressant, Uric acid biosynthesis inhibitor, Xanthine oxidase inhibitor\nDISEASE   Primary or secondary gout [DS:H01532]",
    "therapeutic_category": "3943",
    "atc_code": "M04AA01",
    "drug_class": [
      "Cardiovascular agent",
      "Xanthine dehydrogenase inhibitor",
      "Musculo-skeletal system agent",
      "Xanthin oxidase inhibitor",
      "Metabolizing enzyme inhibitor",
      "CYP1A2 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_3943",
    "type": "category",
    "name_ja": "分類3943",
    "name_en": "",
    "code": "3943"
  },
  {
    "id": "D01206",
    "type": "drug",
    "name_en": "Febuxostat (JP18/USAN/INN)",
    "name_ja": "フェブキソスタット",
    "names_alt": [
      "Uloric (TN)",
      "Feburic (TN)"
    ],
    "search_name": "Febuxostat",
    "formula": "C16H16N2O3S",
    "efficacy": "Gout suppressant, Uric acid biosynthesis inhibitor, Xanthine oxidase inhibitor\nDISEASE   Gout [DS:H01532]",
    "therapeutic_category": "3949",
    "atc_code": "M04AA03",
    "drug_class": [
      "Cardiovascular agent",
      "Xanthine dehydrogenase inhibitor",
      "Musculo-skeletal system agent",
      "Xanthin oxidase inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_3949",
    "type": "category",
    "name_ja": "分類3949",
    "name_en": "",
    "code": "3949"
  },
  {
    "id": "D00570",
    "type": "drug",
    "name_en": "Colchicine (JP18/USP)",
    "name_ja": "コルヒチン",
    "names_alt": [],
    "search_name": "Colchicine",
    "formula": "C22H25NO6",
    "efficacy": "Gout suppressant, Leukocyte (neutrophil) migration inhibitor, Tubulin polymerization inhibitor\nDISEASE   Gout flares [DS:H01532]\nFamilial mediterranean fever [DS:H00288]",
    "therapeutic_category": "3941",
    "atc_code": "M04AC01",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_3941",
    "type": "category",
    "name_ja": "分類3941",
    "name_en": "",
    "code": "3941"
  },
  {
    "id": "D01056",
    "type": "drug",
    "name_en": "Benzbromarone (JP18/USAN/INN)",
    "name_ja": "ベンズブロマロン",
    "names_alt": [
      "Uroleap (TN)"
    ],
    "search_name": "Benzbromarone",
    "formula": "C17H12Br2O3",
    "efficacy": "Gout suppressant, Uricosuric",
    "therapeutic_category": "3949",
    "atc_code": "M04AB03",
    "drug_class": [
      "Musculo-skeletal system agent",
      "Uricosurics",
      "Urate transporter inhibitor",
      "Metabolizing enzyme substrate",
      "CYP2C9 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP2C9"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00222",
    "type": "drug",
    "name_en": "Acyclovir (USP)",
    "name_ja": "アシクロビル",
    "names_alt": [
      "Aciclovir (JP18/INN)",
      "Sitavig (TN)",
      "Zovirax (TN)"
    ],
    "search_name": "Acyclovir",
    "formula": "C8H11N5O3",
    "efficacy": "Antiviral, DNA polymerase inhibitor\nDISEASE   Herpes simplex virus infection [DS:H00365]\nHerpes zoster infection [DS:H00366]\nChickenpox [DS:H00366]",
    "therapeutic_category": "1319",
    "atc_code": "D06BB03",
    "drug_class": [
      "Antiviral",
      "Anti-herpesvirus agent",
      "Transporter substrate",
      "SLC22A1 substrate",
      "SLC22A6 substrate",
      "SLC22A8 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00398",
    "type": "drug",
    "name_en": "Valacyclovir hydrochloride (USP)",
    "name_ja": "バラシクロビル",
    "names_alt": [
      "Valaciclovir hydrochloride (JP18)",
      "Valtrex (TN)"
    ],
    "search_name": "Valacyclovir",
    "formula": "C13H20N6O4. HCl",
    "efficacy": "Antiviral, DNA polymerase inhibitor\nDISEASE   Herpes labialis [DS:H00365]\nGenital herpes [DS:H00365]\nHerpes zoster [DS:H00366]\nChickenpox [DS:H00366]",
    "therapeutic_category": "6250",
    "atc_code": "J05AB11",
    "drug_class": [
      "Antiviral",
      "Anti-herpesvirus agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_6250",
    "type": "category",
    "name_ja": "分類6250",
    "name_en": "",
    "code": "6250"
  },
  {
    "id": "D00900",
    "type": "drug",
    "name_en": "Oseltamivir phosphate (JAN/USP)",
    "name_ja": "オセルタミビル",
    "names_alt": [
      "Tamiflu (TN)",
      "Ebilfumin (TN)"
    ],
    "search_name": "Oseltamivir",
    "formula": "C16H28N2O4. H3PO4",
    "efficacy": "Antiviral, Neuraminidase inhibitor\nDISEASE   Influenza [DS:H00398]",
    "therapeutic_category": "6250",
    "atc_code": "J05AH02",
    "drug_class": [
      "Antiviral",
      "Anti-influenza virus agent",
      "Neuraminidase inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D11021",
    "type": "drug",
    "name_en": "Baloxavir marboxil (JAN/USAN/INN)",
    "name_ja": "バロキサビル マルボキシル",
    "names_alt": [
      "Xofluza (TN)"
    ],
    "search_name": "Baloxavir marboxil",
    "formula": "C27H23F2N3O7S",
    "efficacy": "Antiviral, cap-dependent endonuclease inhibitor\nDISEASE   Influenza [DS:H00398]",
    "therapeutic_category": "6250",
    "atc_code": "J05AX25",
    "drug_class": [
      "Antiviral",
      "Anti-influenza virus agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00322",
    "type": "drug",
    "name_en": "Fluconazole (JP18/USP/INN)",
    "name_ja": "フルコナゾール",
    "names_alt": [
      "Diflucan (TN)"
    ],
    "search_name": "Fluconazole",
    "formula": "C13H12F2N6O",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Candidiasis [DS:H00363]\nCryptococcal meningitis [DS:H00364]",
    "therapeutic_category": "6290",
    "atc_code": "D01AC15",
    "drug_class": [
      "Antifungal",
      "Triazole antifungal",
      "Metabolizing enzyme inhibitor",
      "CYP2C9 inhibitor",
      "CYP2C19 inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_6290",
    "type": "category",
    "name_ja": "分類6290",
    "name_en": "",
    "code": "6290"
  },
  {
    "id": "D00350",
    "type": "drug",
    "name_en": "Itraconazole (JP18/USP)",
    "name_ja": "イトラコナゾール",
    "names_alt": [
      "Itrizole (TN)",
      "Sporanox (TN)\nABBR      ITC"
    ],
    "search_name": "Itraconazole",
    "formula": "C35H38Cl2N8O4",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Blastomycosis [DS:H01501]\nHistoplasmosis [DS:H01062]\nAspergillosis [DS:H01328]\nOnychomycosis of the toenail, fingernail [DS:H01316]",
    "therapeutic_category": "6290",
    "atc_code": "J02AC02",
    "drug_class": [
      "Antifungal",
      "Triazole antifungal",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D02219",
    "type": "drug",
    "name_en": "Terbinafine hydrochloride (JP18/USP)",
    "name_ja": "テルビナフィン",
    "names_alt": [
      "Lamisil (TN)"
    ],
    "search_name": "Terbinafine",
    "formula": "C21H25N. HCl",
    "efficacy": "Antifungal, Ergosterol biosynthesis inhibitor\nDISEASE   Onychomycosis [DS:H01316]\nTinea unguium [DS:H01316]\nTinea capitis [DS:H01316]",
    "therapeutic_category": "2659",
    "atc_code": "D01AE15",
    "drug_class": [
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2C8 substrate",
      "CYP2C9 substrate",
      "CYP2C19 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP2D6 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP1A2",
      "CYP2C9",
      "CYP2C8",
      "CYP2C19",
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_2659",
    "type": "category",
    "name_ja": "分類2659",
    "name_en": "",
    "code": "2659"
  },
  {
    "id": "D00107",
    "type": "drug",
    "name_en": "Tacrolimus (USP/INN)",
    "name_ja": "タクロリムス",
    "names_alt": [
      "Tacrolimus hydrate (JP18)",
      "Prograf (TN)",
      "Protopic (TN)"
    ],
    "search_name": "Tacrolimus",
    "formula": "C44H69NO12. H2O",
    "efficacy": "Antiallergic, Immunosuppressant, Calcineurin inhibitor\nDISEASE   Organ rejection in kidney transplant [DS:H00083]\nOrgan rejection in liver transplant [DS:H00083]\nOrgan rejection in heart transplant [DS:H00083]\nAtopic dermatitis [DS:H01358]",
    "therapeutic_category": "1319",
    "atc_code": "D11AH01",
    "drug_class": [
      "Immunological agent",
      "Calcineurin inhibitor",
      "Anti-inflammatory",
      "Disease modifying anti-rheumatic drug (DMARD)",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00184",
    "type": "drug",
    "name_en": "Cyclosporine (USP)",
    "name_ja": "シクロスポリン",
    "names_alt": [
      "Ciclosporin (JP18)",
      "Gengraf (TN)",
      "Neoral (TN)",
      "Restasis (TN)",
      "Sandimmune (TN)"
    ],
    "search_name": "Cyclosporine",
    "formula": "C62H111N11O12",
    "efficacy": "Immunosuppressant, Calcineurin inhibitor\nDISEASE   Keratoconjunctivitis sicca [DS:H01641]\nOrgan rejection in kidney, liver, and heart allogeneic transplants [DS:H00083]\nRheumatoid arthritis [DS:H00630]\nPsoriasis [DS:H01656]",
    "therapeutic_category": "1319",
    "atc_code": "L04AD01",
    "drug_class": [
      "Immunological agent",
      "Calcineurin inhibitor",
      "Dermatological agent",
      "Atopic dermatitis agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Metabolizing enzyme inhibitor",
      "CYP3A/CYP3A4 inhibitor",
      "CYP3A4 inhibitor",
      "Transporter inhibitor",
      "ABCB1 inhibitor"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00752",
    "type": "drug",
    "name_en": "Mycophenolate mofetil (JAN/USP)",
    "name_ja": "ミコフェノール酸モフェチル",
    "names_alt": [
      "Cellcept (TN)"
    ],
    "search_name": "Mycophenolate mofetil",
    "formula": "C23H31NO7",
    "efficacy": "Immunosuppressant, Inosine monophosphate dehydrogenase inhibitor\nDISEASE   Prophylaxis of organ rejection [DS:H00083]",
    "therapeutic_category": "3999",
    "atc_code": "L04AA06",
    "drug_class": [],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00300",
    "type": "drug",
    "name_en": "Diphenhydramine (JP18/INN)",
    "name_ja": "ジフェンヒドラミン",
    "names_alt": [
      "Restamin (TN)"
    ],
    "search_name": "Diphenhydramine",
    "formula": "C17H21NO",
    "efficacy": "Antiallergic, H1 receptor antagonist",
    "therapeutic_category": "2642",
    "atc_code": "D04AA32",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2642",
    "type": "category",
    "name_ja": "分類2642",
    "name_en": "",
    "code": "2642"
  },
  {
    "id": "D00665",
    "type": "drug",
    "name_en": "Chlorpheniramine maleate (JP18/USP)",
    "name_ja": "クロルフェニラミン",
    "names_alt": [
      "Chlor-trimeton (TN)",
      "Teldrin (TN)"
    ],
    "search_name": "Chlorpheniramine",
    "formula": "C16H19ClN2. C4H4O4",
    "efficacy": "Antiallergic, H1 receptor antagonist",
    "therapeutic_category": "4419",
    "atc_code": "R06AB04",
    "drug_class": [
      "Anti-allergic agent",
      "Histamine receptor antagonist",
      "Histamine receptor H1 antagonist"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_4419",
    "type": "category",
    "name_ja": "分類4419",
    "name_en": "",
    "code": "4419"
  },
  {
    "id": "D00528",
    "type": "drug",
    "name_en": "Caffeine (USP)",
    "name_ja": "カフェイン",
    "names_alt": [
      "Anhydrous caffeine (JP18)",
      "Anhydrous caffeine (TN)",
      "Respia (TN)"
    ],
    "search_name": "Caffeine",
    "formula": "C8H10N4O2",
    "efficacy": "Stimulant (central), Adenosine receptor antagonist, Phosphodiesterase inhibitor",
    "therapeutic_category": "2115",
    "atc_code": "D11AX26",
    "drug_class": [
      "Respiratory system agent",
      "Xanthine derivative",
      "Xanthine-type central nervous system stimulant",
      "Metabolizing enzyme substrate",
      "CYP1A2 substrate",
      "CYP2E1 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP1A2",
      "CYP2E1",
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_2115",
    "type": "category",
    "name_ja": "分類2115",
    "name_en": "",
    "code": "2115"
  },
  {
    "id": "D00729",
    "type": "drug",
    "name_en": "Loperamide hydrochloride (JAN/USP)",
    "name_ja": "ロペラミド",
    "names_alt": [
      "Imodium (TN)"
    ],
    "search_name": "Loperamide",
    "formula": "C29H33ClN2O2. HCl",
    "efficacy": "Antidiarrheal, Antiperistaltic, Opioid receptor agonist",
    "therapeutic_category": "2319",
    "atc_code": "A07DA03",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "Metabolizing enzyme substrate",
      "CYP2C8 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [
      "CYP2C8",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "便秘",
        "name_en": "Constipation",
        "frequency": "high"
      },
      {
        "name": "悪心・嘔吐",
        "name_en": "Nausea/vomiting",
        "frequency": "high"
      },
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "呼吸抑制",
        "name_en": "Respiratory depression",
        "frequency": "medium"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      }
    ]
  },
  {
    "id": "cat_2319",
    "type": "category",
    "name_ja": "分類2319",
    "name_en": "",
    "code": "2319"
  },
  {
    "id": "D00728",
    "type": "drug",
    "name_en": "Bismuth subsalicylate (JAN/USP)",
    "name_ja": "次サリチル酸ビスマス",
    "names_alt": [
      "Pepto-bismol (TN)"
    ],
    "search_name": "Bismuth",
    "formula": "C7H5BiO4",
    "efficacy": "Antacid, Antidiarrheal, Anti-ulcerative",
    "therapeutic_category": "",
    "atc_code": "",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Antacid"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D01167",
    "type": "drug",
    "name_en": "Magnesium oxide (JP18/USP)",
    "name_ja": "酸化マグネシウム",
    "names_alt": [
      "Magmitt (TN)"
    ],
    "search_name": "Magnesium oxide",
    "formula": "MgO",
    "efficacy": "Antacid, Laxative, Pharmaceutic aid (sorbent)",
    "therapeutic_category": "2344",
    "atc_code": "A02AA02",
    "drug_class": [
      "Gastrointestinal agent",
      "Agents for peptic ulcer",
      "Antacid",
      "Laxative",
      "Magnesium containing preparation"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2344",
    "type": "category",
    "name_ja": "分類2344",
    "name_en": "",
    "code": "2344"
  },
  {
    "id": "D02060",
    "type": "drug",
    "name_en": "Potassium chloride (JP18/USP)",
    "name_ja": "塩化カリウム",
    "names_alt": [
      "K-dur (TN)",
      "KCL (TN)",
      "Kaon-Cl (TN)",
      "Klor-con (TN)",
      "Klotrix (TN)"
    ],
    "search_name": "Potassium chloride",
    "formula": "K. Cl",
    "efficacy": "Supplement (potassium), Replenisher (electrolyte)\nDISEASE   Hypokalemic familial periodic paralysis [DS:H00746]",
    "therapeutic_category": "3229",
    "atc_code": "A12BA01",
    "drug_class": [
      "Gastrointestinal agent",
      "Potassium"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_3229",
    "type": "category",
    "name_ja": "分類3229",
    "name_en": "",
    "code": "3229"
  },
  {
    "id": "D00331",
    "type": "drug",
    "name_en": "Furosemide (JP18/USP/INN)",
    "name_ja": "フロセミド",
    "names_alt": [
      "Frusemide",
      "Lasix (TN)"
    ],
    "search_name": "Furosemide",
    "formula": "C12H11ClN2O5S",
    "efficacy": "Diuretic, Na-K-Cl cotransporter inhibitor\nDISEASE   Hypertension [DS:H01633]",
    "therapeutic_category": "2139",
    "atc_code": "C03CA01",
    "drug_class": [
      "Cardiovascular agent",
      "Sulfonamide diuretic",
      "Furosemide type diuretic",
      "Loop diuretic",
      "Furosemide type diuretic",
      "Transporter substrate",
      "ABCC4 substrate",
      "SLC22A6 substrate",
      "SLC22A8 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2139",
    "type": "category",
    "name_ja": "分類2139",
    "name_en": "",
    "code": "2139"
  },
  {
    "id": "D00340",
    "type": "drug",
    "name_en": "Hydrochlorothiazide (JP18/USP/INN)",
    "name_ja": "ヒドロクロロチアジド",
    "names_alt": [
      "Esidrix (TN)",
      "Microzide (TN)"
    ],
    "search_name": "Hydrochlorothiazide",
    "formula": "C7H8ClN3O4S2",
    "efficacy": "Antihypertensive, Diuretic, Na+-Cl- symport inhibitor\nDISEASE   Hypertension [DS:H01633]",
    "therapeutic_category": "2132",
    "atc_code": "C03AA03",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Thiazide diuretic",
      "Sulfonamide diuretic",
      "Thiazide diuretic"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2132",
    "type": "category",
    "name_ja": "分類2132",
    "name_en": "",
    "code": "2132"
  },
  {
    "id": "D00443",
    "type": "drug",
    "name_en": "Spironolactone (JP18/USP/INN)",
    "name_ja": "スピロノラクトン",
    "names_alt": [
      "Aldactone (TN)"
    ],
    "search_name": "Spironolactone",
    "formula": "C24H32O4S",
    "efficacy": "Antihypertensive, Diuretic, Aldosterone antagonist\nDISEASE   Primary hyperaldosteronism [DS:H01603]\nNephrotic syndrome [DS:H01657]\nEssential hypertension [DS:H01633]",
    "therapeutic_category": "2133",
    "atc_code": "C03DA01",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Aldosterone antagonist",
      "Potassium-sparing diuretic"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2133",
    "type": "category",
    "name_ja": "分類2133",
    "name_en": "",
    "code": "2133"
  },
  {
    "id": "D01115",
    "type": "drug",
    "name_en": "Eplerenone (JP18/USAN/INN)",
    "name_ja": "エプレレノン",
    "names_alt": [
      "Inspra (TN)"
    ],
    "search_name": "Eplerenone",
    "formula": "C24H30O6",
    "efficacy": "Antihypertensive, Aldosterone antagonist\nDISEASE   Hypertension [DS:H01633]",
    "therapeutic_category": "2149",
    "atc_code": "C03DA04",
    "drug_class": [
      "Cardiovascular agent",
      "Antihypertensive",
      "Aldosterone antagonist",
      "Potassium-sparing diuretic",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "D00298",
    "type": "drug",
    "name_en": "Digoxin (JP18/USP)",
    "name_ja": "ジゴキシン",
    "names_alt": [
      "Lanoxicaps (TN)",
      "Lanoxin (TN)"
    ],
    "search_name": "Digoxin",
    "formula": "C41H64O14",
    "efficacy": "Cardiotonic",
    "therapeutic_category": "2113",
    "atc_code": "C01AA05",
    "drug_class": [
      "Cardiovascular agent",
      "Cardiotonic",
      "Cardiac glycoside",
      "Digitalis cardiac glycoside",
      "Antiarrhythmics",
      "Transporter substrate",
      "ABCB1 substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "cat_2113",
    "type": "category",
    "name_ja": "分類2113",
    "name_en": "",
    "code": "2113"
  },
  {
    "id": "D00636",
    "type": "drug",
    "name_en": "Amiodarone hydrochloride (JP18/USP)",
    "name_ja": "アミオダロン",
    "names_alt": [
      "Ancaron (TN)",
      "Cordarone (TN)",
      "Nexterone (TN)"
    ],
    "search_name": "Amiodarone",
    "formula": "C25H29I2NO3. HCl",
    "efficacy": "Antiarrhythmic, Potassium channel blocker",
    "therapeutic_category": "2129",
    "atc_code": "C01BD01",
    "drug_class": [
      "Cardiovascular agent",
      "Adrenergic receptor agonist",
      "beta-Adrenergic receptor agonist",
      "beta1-Adrenergic receptor agonist",
      "Antiarrhythmics",
      "Class III antiarrhythmic agent",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": []
  },
  {
    "id": "cat_2129",
    "type": "category",
    "name_ja": "分類2129",
    "name_en": "",
    "code": "2129"
  },
  {
    "id": "D01810",
    "type": "drug",
    "name_en": "Nicorandil (JP18/USAN/INN)",
    "name_ja": "ニコランジル",
    "names_alt": [
      "Sigmart (TN)"
    ],
    "search_name": "Nicorandil",
    "formula": "C8H9N3O4",
    "efficacy": "Vasodilator (coronary)",
    "therapeutic_category": "2171",
    "atc_code": "C01DX16",
    "drug_class": [
      "Cardiovascular agent",
      "ATP-sensitive potassium channel opener",
      "Nitrovasodilator",
      "Blood modifier agent",
      "Antithrombotic agent",
      "Antiplatelet agent"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D00332",
    "type": "drug",
    "name_en": "Gabapentin (JAN/USP/INN)",
    "name_ja": "ガバペンチン",
    "names_alt": [
      "Neurontin (TN)",
      "Gralise (TN)"
    ],
    "search_name": "Gabapentin",
    "formula": "C9H17NO2",
    "efficacy": "Anticonvulsant, Antiepileptic\nDISEASE   Postherpetic neuralgia [DS:H01624]",
    "therapeutic_category": "1139",
    "atc_code": "N02BF01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "GABA mimetic antiepileptic",
      "Calcium channel alpha-2 delta blocker"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D02716",
    "type": "drug",
    "name_en": "Pregabalin (JAN/USAN/INN)",
    "name_ja": "プレガバリン",
    "names_alt": [
      "Lyrica (TN)"
    ],
    "search_name": "Pregabalin",
    "formula": "C8H17NO2",
    "efficacy": "Anticonvulsant, Pain relief\nDISEASE   Diabetic peripheral neuropathy [DS:H01459]\nPostherpetic neuralgia [DS:H01624]\nFibromyalgia [DS:H01636]",
    "therapeutic_category": "1190",
    "atc_code": "N02BF02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Antiepileptic agent",
      "GABA mimetic antiepileptic",
      "Calcium channel alpha-2 delta blocker"
    ],
    "cyp_enzymes": [],
    "adverse_effects": []
  },
  {
    "id": "D01355",
    "type": "drug",
    "name_en": "Tramadol hydrochloride (JP18/USP)",
    "name_ja": "トラマドール",
    "names_alt": [
      "Ultram (TN)"
    ],
    "search_name": "Tramadol",
    "formula": "C16H25NO2. HCl",
    "efficacy": "Analgesic, Opioid receptor agonist",
    "therapeutic_category": "1149",
    "atc_code": "N02AX02",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "便秘",
        "name_en": "Constipation",
        "frequency": "high"
      },
      {
        "name": "悪心・嘔吐",
        "name_en": "Nausea/vomiting",
        "frequency": "high"
      },
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "呼吸抑制",
        "name_en": "Respiratory depression",
        "frequency": "medium"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      }
    ]
  },
  {
    "id": "D00842",
    "type": "drug",
    "name_en": "Morphine sulfate (USP)",
    "name_ja": "モルヒネ",
    "names_alt": [
      "Morphine sulfate hydrate (JP18)",
      "Morphine sulfate pentahydrate",
      "Astramor PH (TN)",
      "Avinza (TN)",
      "Depodur (TN)",
      "Kadian (TN)",
      "MS contin (TN)"
    ],
    "search_name": "Morphine",
    "formula": "(C17H19NO3)2. H2SO4. 5H2O",
    "efficacy": "Analgesic (narcotic), Opioid receptor agonist",
    "therapeutic_category": "8114",
    "atc_code": "N02AA01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "UGT substrate"
    ],
    "cyp_enzymes": [],
    "adverse_effects": [
      {
        "name": "便秘",
        "name_en": "Constipation",
        "frequency": "high"
      },
      {
        "name": "悪心・嘔吐",
        "name_en": "Nausea/vomiting",
        "frequency": "high"
      },
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "呼吸抑制",
        "name_en": "Respiratory depression",
        "frequency": "medium"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      }
    ]
  },
  {
    "id": "cat_8114",
    "type": "category",
    "name_ja": "分類8114",
    "name_en": "",
    "code": "8114"
  },
  {
    "id": "D00320",
    "type": "drug",
    "name_en": "Fentanyl (JAN/USP/INN)",
    "name_ja": "フェンタニル",
    "names_alt": [
      "Duragesic (TN)",
      "Subsys (TN)"
    ],
    "search_name": "Fentanyl",
    "formula": "C22H28N2O",
    "efficacy": "Analgesic (narcotic), Opioid receptor agonist",
    "therapeutic_category": "8219",
    "atc_code": "N01AH01",
    "drug_class": [
      "Neuropsychiatric agent",
      "Anesthetics",
      "General anesthetics",
      "Opioid anesthetics",
      "Opioid receptor agonist",
      "mu-Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "便秘",
        "name_en": "Constipation",
        "frequency": "high"
      },
      {
        "name": "悪心・嘔吐",
        "name_en": "Nausea/vomiting",
        "frequency": "high"
      },
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "呼吸抑制",
        "name_en": "Respiratory depression",
        "frequency": "medium"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      }
    ]
  },
  {
    "id": "cat_8219",
    "type": "category",
    "name_ja": "分類8219",
    "name_en": "",
    "code": "8219"
  },
  {
    "id": "D00847",
    "type": "drug",
    "name_en": "Oxycodone hydrochloride (USP)",
    "name_ja": "オキシコドン",
    "names_alt": [
      "Oxecta (TN)",
      "Oxycontin (TN)",
      "Roxicodone (TN)"
    ],
    "search_name": "Oxycodone",
    "formula": "C18H21NO4. HCl",
    "efficacy": "Analgesic (narcotic), Opioid receptor agonist",
    "therapeutic_category": "",
    "atc_code": "N02AA05",
    "drug_class": [
      "Neuropsychiatric agent",
      "Opioid receptor agonist",
      "Analgesic",
      "Opioid analgesics",
      "Metabolizing enzyme substrate",
      "CYP2D6 substrate",
      "CYP3A/CYP3A4 substrate",
      "CYP3A4 substrate"
    ],
    "cyp_enzymes": [
      "CYP2D6",
      "CYP3A4"
    ],
    "adverse_effects": [
      {
        "name": "便秘",
        "name_en": "Constipation",
        "frequency": "high"
      },
      {
        "name": "悪心・嘔吐",
        "name_en": "Nausea/vomiting",
        "frequency": "high"
      },
      {
        "name": "眠気",
        "name_en": "Somnolence",
        "frequency": "high"
      },
      {
        "name": "呼吸抑制",
        "name_en": "Respiratory depression",
        "frequency": "medium"
      },
      {
        "name": "依存性",
        "name_en": "Dependence",
        "frequency": "high"
      }
    ]
  }
]